78. 下垂体前葉機能低下症 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 492 / 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100
薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。
ACP-001
ASCENDIS PHARMA A/S
2010 - EUCTR2010-021523-28-IT Austria;Denmark;Germany;Italy;Sweden;
Ascendis Pharma A/S
2013 Phase 2 NCT01947907 Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-GR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2010 - EUCTR2010-021523-28-SE Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-DK Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-DE Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-AT Austria;Denmark;Germany;Italy;Sweden;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
ACP-001 (TransCon hGH)
Ascendis Pharma A/S
2010 Phase 2 NCT01247675 Denmark;Germany;Italy;Sweden;
ACP-011
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
AEZS-130
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002337-22-IT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
2016 Phase 3 EUCTR2015-002337-22-PL Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002337-22-DE Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002337-22-GB Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002337-22-AT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
AEZS-130 (formerly ARD-07)
AEterna Zentaris
2007 Phase 3 NCT00448747 United States;
AGUA PARA PREPARACIONES INYECTABLES
Ipsen Pharma
2011 - EUCTR2010-020742-10-ES Finland;Spain;Sweden;United Kingdom;
ALRN-5281
Aileron Therapeutics
2013 Phase 1 NCT01775358 United States;
ALTU-238
Altus Pharmaceuticals
2005 Phase 2 NCT00297713 United States;
ARGININA CLORIDRATO
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
ARX201
Ambrx, Inc.
2008 Phase 2 NCT00778518 Hungary;
Ambrx, Inc., USA
2008 - EUCTR2007-001746-40-HU Hungary;
Acipimox
University of Aarhus
2016 - NCT02782208 Denmark;
2012 - NCT01209416 Denmark;
Albutropin
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-003796-32-PL Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-SI Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-HR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-GR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-DE Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-CZ Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-AT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-SK Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-RO Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-LT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-IT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-HU Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-ES Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-BG Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2013 Phase 2 EUCTR2012-004975-37-DE Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SK Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SI Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-SE Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-HU Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-GR Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-CZ Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Amitriptyline, fluoxetine and tramadol alone (control group)
Centro Medico Teknon
2004 Phase 2 NCT00497562 Spain;
Arg
Merck KGaA
2004 Phase 3 NCT01060488 France;
Arginin
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Arginine
AEterna Zentaris
2021 Phase 3 NCT04786873 United States;
Helsinki University Central Hospital
2001 - NCT03018886 Finland;
Osaka City University Graduate School of Medicine
2017 - JPRN-UMIN000027260 Japan;
Arginine and Clonidine Stimulation Testing
The University of Texas Health Science Center at San Antonio
2001 Phase 3 NCT00134420 United States;
Arginine stimulation test after each limb
Christie Hospital NHS Foundation Trust
2004 - NCT00468624 United Kingdom;
Aricept
Ludwig Boltzmann Gesellschaft
2006 - EUCTR2005-001315-22-AT Austria;
Arimidex
Nemours Children's Clinic
- - EUCTR2012-001183-30-Outside-EU/EEA United States;
Arimidex (Anastrozole)
Nemours Children's Clinic
2001 Phase 2/Phase 3 NCT00133354 United States;
Audiological and ear, nose and throat examination
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
BPLG-003
BioPartners GmbH
2003 Phase 2/Phase 3 NCT00600808 -
Behavior and neuropsychometric evaluations
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Biopsy
University Hospital, Toulouse
2009 Phase 4 NCT01298180 France;
Blood draws
Columbia University
2007 - NCT00720902 United States;
Blood sampling before
Christie Hospital NHS Foundation Trust
2004 - NCT00468624 United Kingdom;
Byetta
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
2021 Phase 2 EUCTR2020-004115-27-ES Spain;
CLONIDINA CLORIDRATO
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
CLONIDINE HYDROCHLORIDE
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Carotid ultrasound
Columbia University
2007 - NCT00720902 United States;
Catapresan
Centre for Human Drug Research
2007 - EUCTR2006-003678-82-NL Netherlands;
Catapresan 75
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
Change in daily dosage of Growth Hormone
VU University Medical Center
2013 Phase 4 NCT01877512 Netherlands;
Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001)
Hanmi Pharmaceutical Co., Ltd.
2014 - EUCTR2011-001826-61-BG Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2012 - EUCTR2011-001826-61-PL Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2011 - EUCTR2011-001826-61-HU Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
CinnaTropin®
Cinnagen
2016 Phase 3 NCT03223025 -
Clonidin
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Clonidine
AEterna Zentaris
2021 Phase 3 NCT04786873 United States;
Clonidine HCl CF 0,150 mg, tabletten
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Corticotropin
Max-Planck-Institute of Psychiatry
2008 - NCT00666068 Germany;
DEXA, blood tests, H.G.P.O, osseous age.
University Hospital, Toulouse
2009 Phase 4 NCT01298180 France;
DGH
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 3 NCT02410356 Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Daily hGH
Visen Pharmaceuticals (Shanghai) Co., Ltd.
2019 Phase 3 NCT04326374 China;
Daily rhGH
Versartis Inc.
2015 Phase 3 NCT02339090 Belgium;Canada;Netherlands;Poland;Sweden;United States;
Dental evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Determination of growth hormone status
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Dextromethorphan and Caffeine
University of Louisville
2001 - NCT00458991 United States;
Donepezil
Ludwig Boltzmann Gesellschaft
2006 - EUCTR2005-001315-22-AT Austria;
Dose-Establishing Study 1 Niacin
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2011 Phase 1/Phase 2 NCT01237041 United States;
Dose-Establishing Study 2 Niacin
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2011 Phase 1/Phase 2 NCT01237041 United States;
Dysmorphology evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Ecombinanat DNA-derived human growth h
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Emcitate
Rare Thyroid Therapeutics International
2020 Phase 2 EUCTR2019-003370-35-IT Czech Republic;Czechia;France;Germany;Italy;Netherlands;United Kingdom;United States;
Rare Thyroid Therapeutics International AB
2020 Phase 2 EUCTR2019-003370-35-GB Czech Republic;France;Germany;Italy;Netherlands;United Kingdom;United States;
Endothelial cell biopsy
Columbia University
2007 - NCT00720902 United States;
Eutropin
Daewoong Pharmaceutical Co. LTD.
2003 Phase 3 NCT02693522 Korea, Republic of;
Experimental: CRH administration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2021 Phase 4 NCT04902235 Spain;
Experimental: GLP1-RA (exenatide) administration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2021 Phase 4 NCT04897802 Spain;
Experimental: VRS-317
Versartis Inc.
2012 Phase 1/Phase 2 NCT01718041 United States;
Fat diet
University Hospital Inselspital, Berne
2011 - NCT01467193 Switzerland;
GENOTROPIN 12 mg powder and solvent for solution for injection.
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
GH sampling - every 20 min over 24 hours
Christie Hospital NHS Foundation Trust
2004 - NCT00468624 United Kingdom;
GH substitution
University of Aarhus
2016 - NCT02782208 Denmark;
GHRH
Helsinki University Central Hospital
2001 - NCT03018886 Finland;
Merck KGaA
2004 Phase 3 NCT01060488 France;
GHRH/arginine stimulation testing
Children's Mercy Hospital Kansas City
2007 - NCT00324064 United States;
GX-H9
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
Genexine, Inc.
2016 Phase 2 NCT03309891 Ukraine;
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 NCT02946606 Korea, Republic of;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
Gastrointestinal evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Gelatin
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Genotonorm Kabipen 5.3 mg polvo y disolvente para sol. inyectable (Marca internacional Genotropin)
Pfizer, S.A
2007 Phase 4 EUCTR2007-003586-41-ES France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotonorm Kabipen 5.3 mg polvo y disolvente para solución inyectable (Marca internacional Genotropin)
Pfizer, S.A
2007 Phase 4 EUCTR2007-003586-41-ES France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotropin
Ascendis Pharma A/S
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-GR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
BioPartners GmbH
2006 - EUCTR2005-000346-36-LT Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-SE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-FI Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-DE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
Cristália Produtos Químicos Farmacêuticos Ltda.
- - EUCTR2016-000446-56-Outside-EU/EEA Brazil;
Ferring Pharmaceuticals
2010 Phase 3 NCT00884000 Hungary;India;Israel;Poland;Romania;Russian Federation;Ukraine;
Genexine, Inc.
2016 Phase 2 NCT03309891 Ukraine;
2015 Phase 2 NCT02946606 Korea, Republic of;
Hanmi Pharmaceutical Co., Ltd.
2014 - EUCTR2011-001826-61-BG Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2012 - EUCTR2011-001826-61-PL Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2011 - EUCTR2011-001826-61-HU Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
Hanmi Pharmaceutical Company Limited
2011 Phase 2 NCT01822340 Hungary;Romania;
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
OPKO Biologics Ltd.
2017 Phase 3 EUCTR2016-003874-42-GR Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-GB Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-ES Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-DE Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-BG Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004553-60-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 Phase 2 EUCTR2011-004553-60-HU Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 - EUCTR2011-004553-60-SK Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 - EUCTR2011-004553-60-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
- Phase 3 EUCTR2016-003874-42-PL Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-FR Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
2017 Phase 3 JPRN-JapicCTI-183963 Japan;
OPKO Health, Inc.
2017 Phase 3 NCT03874013 Japan;
PFIZER
2008 - EUCTR2007-003586-41-IT France;Italy;Netherlands;Spain;Sweden;United Kingdom;
PRM|21097
2017 Phase 3 EUCTR2016-003874-42-IT Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
PROLOR Biotech Ltd.
2012 - EUCTR2011-004553-60-GR Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
2012 - EUCTR2011-004553-60-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Pfizer
2019 Phase 3 NCT03831880 Bulgaria;Czechia;Slovakia;United Kingdom;United States;
2008 Phase 4 NCT00555009 France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2007 - EUCTR2007-003586-41-SE France;Italy;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003586-41-NL France;Italy;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003586-41-GB France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Radboud University Nijmegen Medical Centre, Department of Endocrinology
2006 Phase 4 EUCTR2006-001574-24-NL Netherlands;
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
VU University Medical Center
2013 - EUCTR2012-005066-36-NL Netherlands;
Genotropin (PN-180,307) Somatropin
Pfizer
2007 Phase 4 NCT00432263 -
Genotropin 12 mg/ml
Ferring Pharmaceuticals A/S
2009 - EUCTR2008-004849-28-HU Hungary;
Genotropin 5 mg/ml
Pfizer Pharma GmbH
2008 - EUCTR2007-000790-36-DE Germany;
Genotropin 5.3 mg in injection system Genotropin pen
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2010 Phase 3 EUCTR2009-017354-12-SK Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
Genotropin GoQuick
Pfizer Inc.
2019 Phase 3 EUCTR2018-000918-38-SK Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-GB Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-CZ Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-BG Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Genotropin Mark VII pen
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2010 Phase 3 EUCTR2009-017354-12-SK Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-017354-12-GB Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-SE Czech Republic;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-DE Czech Republic;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-CZ Czech Republic;Germany;Sweden;United Kingdom;
- Phase 3 EUCTR2009-017354-12-NL Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
Genotropin MiniQuick
Dr. Chris Thompson
2006 - EUCTR2005-005613-38-IE Ireland;
Genotropin Miniqu
Amar Agha, Beaumont Hospital
2009 - EUCTR2009-010918-30-IE Ireland;
Genotropin Miniquick
Amar Agha, Beaumont Hospital
2009 - EUCTR2009-010918-30-IE Ireland;
Genotropin miniquick 0.5 mg, injection
University of Aarhus
2019 - NCT03878992 Denmark;
Genotropin, Genotropin MiniQuick
Sahlgrenska University Hospital
2010 - EUCTR2009-016783-37-SE Sweden;
Genotropin/GENOTONORM®
Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2008 - EUCTR2007-003586-41-FR France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotropin®
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
Genexine, Inc.
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
Teva Pharmaceutical Industries Ltd.
2013 Phase 2 EUCTR2012-004975-37-DE Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SK Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SI Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-SE Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-HU Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-GR Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-CZ Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Ghrelin
University of Aarhus
2012 - NCT01209416 Denmark;
Glucagon stimulation test and insulin tolerance test
The Cleveland Clinic
2011 - NCT01282164 United States;
Growth Factors Laboratory Testing
The University of Texas Health Science Center at San Antonio
2001 Phase 3 NCT00134420 United States;
Growth Hormone Replacement Therapy
University of Liverpool
2014 - NCT02243852 United Kingdom;
Growth Hormone, GH
University of Birmingham
2005 - EUCTR2004-004835-72-GB United Kingdom;
Growth Hormone-Releasing Hormone
Stefania La Grutta, MD
2014 - NCT02507245 -
Growth hormone
Columbia University
2017 - NCT03225755 United States;
Ferring Pharmaceuticals
2007 - NCT01365351 Germany;
LG Life Sciences
2006 Phase 3 NCT00294619 United States;
National Center for Research Resources (NCRR)
1997 - NCT00006394 United States;
Ohio State University
2005 Phase 4 NCT00373386 United States;
Royal Liverpool University hospital
2006 Phase 4 EUCTR2005-004316-73-GB United Kingdom;
University Hospital, Angers
2005 - NCT00187993 France;
University of Palermo
2016 - NCT03203356 Italy;
Growth hormone (Genotonorm® or Omnitrope®)
University Hospital, Toulouse
2009 Phase 4 NCT01298180 France;
Growth hormone (Genotropin)
Oregon Health and Science University
2006 Phase 0 NCT00517062 United States;
Growth hormone (Nutropin)
Baylor College of Medicine
2006 - NCT00362063 United States;
Growth hormone (genotropin)
University of Aarhus
2008 - NCT00646815 Denmark;
Growth hormone (somatropin)
LG Life Sciences
2005 Phase 3 NCT00271518 United States;
Growth hormone - LB03002
LG Life Sciences
2006 Phase 3 NCT00596037 United States;
Growth hormone administration for 6 months
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2005 - NCT00149708 Brazil;
Growth hormone releasing hormone (GHRH) 1-44
Massachusetts General Hospital
2008 Phase 2 NCT00675506 United States;
Growth hormone releasing hormone (GHRH) and arginine
Columbia University
2007 - NCT00720902 United States;
Growth hormone replacement therapy in growth hormone deficient patients only.
University Hospital Inselspital, Berne
2007 - NCT00491582 Switzerland;
H01AC01
Sahlgrenska University Hospital
2010 - EUCTR2009-016783-37-SE Sweden;
HGH
Beckert Michael
2021 Phase 3 JPRN-jRCT2051200129 Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
2021 Phase 3 JPRN-jRCT2031200340 Japan;
HGH-ViaDerm™ System (hGH or somatropin)
Teva Neuroscience, Inc.
2007 Phase 1 NCT00455260 Israel;Ukraine;
HGH-hyFc, recombinant human growth hormone
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
Genexine, Inc.
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
HM10560A
Hanmi Pharmaceutical Co., Ltd.
2014 - EUCTR2011-001826-61-BG Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2012 - EUCTR2011-001826-61-PL Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2011 - EUCTR2011-001826-61-HU Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
Hanmi Pharmaceutical Company Limited
2011 Phase 2 NCT01822340 Hungary;Romania;
HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH)
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Humalog Mix50 100 U/ml sospensione iniettabile
AETERNA ZENTARIS GMBH
2016 Phase 3 EUCTR2015-002337-22-IT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Human Growth Hormone (1-134)
Stanford University
2009 Phase 3 NCT01007071 United States;
Human Serum Albumin (HSA) fused to somatropin
Teva Pharmaceutical Industries Ltd.
2013 Phase 2 EUCTR2012-004975-37-DE Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SK Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SI Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-SE Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-HU Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-GR Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-CZ Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Human acylated ghrelin
University of Aarhus
2005 - NCT00139945 Denmark;
Human growth hormone
Federico II University
2019 Phase 3 NCT03775993 -
Humatrope
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
VU University Medical Center
2013 - EUCTR2012-005066-36-NL Netherlands;
Humatrope® 6 mg, powder and solvent for solution for injection
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Hydrocortisone
Amar Agha
2008 - EUCTR2007-005018-37-IE Ireland;
University Hospital Inselspital, Berne
2015 - NCT02360046 Switzerland;
Hydrocortisone TAKEDA, tabletter
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark;
Hydrocortone
Amar Agha
2008 - EUCTR2007-005018-37-IE Ireland;
Bradford Teaching Hospitals NHS Foundation Trust
2004 Phase 4 EUCTR2004-002056-34-GB United Kingdom;
Hydrokortison Glostrup
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark;
INCRELEX 10 mg/ml
Ipsen Pharma
2011 - EUCTR2010-020742-10-SE Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-GB Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-FI Finland;Spain;Sweden;United Kingdom;
INCRELEX 10 mg/ml, solución inyectable
Ipsen Pharma
2011 - EUCTR2010-020742-10-ES Finland;Spain;Sweden;United Kingdom;
Insulin
AETERNA ZENTARIS GMBH
2016 Phase 3 EUCTR2015-002337-22-IT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
AEterna Zentaris
2015 Phase 3 NCT02558829 Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Intravenous Infusion of Diclofenac Sodium
Azienda Ospedaliera Città della Salute e della Scienza di Torino
2021 Phase 4 NCT05188131 Italy;
Jintropin AQ
GeneScience Pharmaceuticals Co., Ltd.
2006 Phase 2 NCT01342146 -
L-ARG+GHRH
AEterna Zentaris
2007 Phase 3 NCT00448747 United States;
LB03002
BIOPARTNERS GMBH
2007 - EUCTR2006-002278-24-IT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-000384-26-IT Czech Republic;Germany;Italy;Spain;Sweden;United Kingdom;
BioPartners GmbH
2015 Phase 3 EUCTR2005-000384-26-FR Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-002278-24-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-SE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-FR Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-ES Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-DE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-CZ Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-000346-36-LT Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 Phase 3 EUCTR2005-000384-26-SK Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2005-000384-26-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-SE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-DE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-CZ Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000346-36-SE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-FI Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-DE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
LG Life Science Ltd.
2005 - EUCTR2005-000384-26-ES Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-AT Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
LG Life Sciences Ltd.
2007 Phase 3 EUCTR2006-002278-24-SK Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-AT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
LUM-201
Lumos Pharma
2022 Phase 2 NCT05250063 United States;
2021 Phase 2 NCT04806854 Chile;
2020 Phase 2 NCT04614337 Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Lumos Pharma, Inc.
2021 Phase 2 EUCTR2020-000874-92-PL Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Levothyroxine
Christie Hospital NHS Trust
2005 - EUCTR2004-005184-15-GB United Kingdom;
Rigshospitalet, Denmark
2012 - NCT01574859 Denmark;
Lonapegsomatropin
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 NCT05171855 United States;
2020 Phase 3 NCT04615273 Armenia;Australia;Canada;Georgia;Greece;Japan;Poland;Slovakia;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-PL Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-IT Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-GR Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-BG Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Beckert Michael
2021 Phase 3 JPRN-jRCT2051200129 Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
2021 Phase 3 JPRN-jRCT2031200340 Japan;
Lonapegsomatropin drug product
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Long-Acting Growth Hormone (LAGH)
University of Minnesota
2021 - NCT04938466 United States;
MACIMORELIN ACETATE
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
2019 Phase 2 EUCTR2018-001988-23-PL Belarus;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2018 Phase 2 EUCTR2018-001988-23-HU Hungary;Poland;Russian Federation;Serbia;Ukraine;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
MOD-4023
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
OPKO Biologics Ltd.
2017 Phase 3 EUCTR2016-003874-42-GR Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-GB Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-ES Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-DE Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-BG Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-000830-37-PL Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-000830-37-NL Austria;France;Germany;Greece;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-SK Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-HU Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-GB Armenia;Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-AT Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004553-60-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 Phase 2 EUCTR2011-004553-60-HU Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 - EUCTR2011-004553-60-SK Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 - EUCTR2011-004553-60-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
- Phase 3 EUCTR2016-003874-42-PL Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-FR Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
OPKO Health, Inc.
2017 Phase 3 NCT03874013 Japan;
2016 Phase 3 NCT02968004 Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;Georgia;Germany;Greece;India;Israel;Italy;Korea, Republic of;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 1 NCT02418767 United States;
2013 Phase 3 NCT01909479 Israel;United States;
2013 Phase 2 NCT02500316 Belarus;Greece;Hungary;Russian Federation;Slovakia;Ukraine;United States;
2012 Phase 2 NCT01592500 Greece;Hungary;Slovakia;
2010 Phase 2 NCT01225666 Czech Republic;Czechia;Hungary;Israel;Serbia;Slovakia;Slovenia;
PRM|21097
2017 Phase 3 EUCTR2016-003874-42-IT Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
PROLOR Biotech Ltd.
2013 Phase 3 EUCTR2013-000830-37-GR Austria;France;Germany;Greece;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-ES Austria;France;Germany;Greece;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004553-60-GR Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
2012 - EUCTR2011-004553-60-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Prolor Biotech Ltd
2010 - EUCTR2010-019374-32-CZ Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
MRI
Columbia University
2007 - NCT00720902 United States;
Macimorelin
AEterna Zentaris
2021 Phase 3 NCT04786873 United States;
2015 Phase 3 NCT02558829 Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Macimorelin Consilient Health
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
Macimorelin acetate
AETERNA ZENTARIS GMBH
2016 Phase 3 EUCTR2015-002337-22-IT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Macimorelina
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Macrilen
Aeterna Zentaris GmbH
2019 Phase 2 EUCTR2018-001988-23-PL Belarus;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2018 Phase 2 EUCTR2018-001988-23-HU Hungary;Poland;Russian Federation;Serbia;Ukraine;
Magnetic resonance imaging of the brain
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Measurement of growth, thyroid and sex hormone levels
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Mecasermin
Ipsen Pharma
2011 - EUCTR2010-020742-10-SE Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-GB Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-FI Finland;Spain;Sweden;United Kingdom;
NDC0009-0436-01
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
NN-220
Novo Nordisk A/S
- Phase 3 EUCTR2017-000914-47-Outside-EU/EEA Japan;
NN8630
Novo Nordisk A/S
2008 - EUCTR2008-001061-29-DK Denmark;
NN8640
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
NNC 126-0083
Novo Nordisk A/S
2009 Phase 2 EUCTR2008-008240-25-FR Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-ES Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-SI Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-GB Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-DK Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-BE Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2008 - EUCTR2008-001061-29-DK Denmark;
NNC0195-0092 10 mg/1.5 ml PDS290-10
Novo Nordisk A/S
2016 Phase 2 EUCTR2015-000531-32-SE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-DE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-BE Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-SI Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-AT Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 15 mg/1.5 ml PDS290-15
Novo Nordisk A/S
2016 Phase 2 EUCTR2015-000531-32-SE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-DE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-BE Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-SI Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-AT Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 5 mg/1.5 ml PDS290-10
Novo Nordisk A/S
2016 Phase 2 EUCTR2015-000531-32-SE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-DE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-BE Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-SI Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-AT Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 DP 6.7 mg ml 3 ml cartridge
Novo Nordisk A/S
2014 Phase 1 EUCTR2013-000013-20-ES Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-SI Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-SE Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-BE Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-AT Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
- Phase 1 EUCTR2013-000013-20-FR Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
NNC0195-0092 PDS290 10 mg-1.5 ml
Novo Nordisk A/S
2015 Phase 3 EUCTR2013-002892-16-LV Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2013-002892-16-LT Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-002892-16-SE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-002892-16-GB Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002892-16-DE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 PDS290 10 mg/1.5 ml
Novo Nordisk A/S
2015 Phase 3 EUCTR2014-000290-39-GB Denmark;European Union;Japan;Sweden;United Kingdom;
2015 - EUCTR2014-000290-39-DK Denmark;European Union;Japan;Sweden;United Kingdom;
2014 - EUCTR2014-000290-39-SE Denmark;European Union;Japan;Sweden;United Kingdom;
NNC126-0083
Novo Nordisk A/S
2009 Phase 2 NCT00936403 Belgium;Czech Republic;Denmark;France;Israel;Macedonia, The Former Yugoslav Republic of;Slovenia;Spain;Turkey;United Kingdom;
2008 Phase 2 NCT00715689 Denmark;
NUTROPIN
Guillem Cuatrecasas Cambra
2012 Phase 2 EUCTR2011-005377-23-ES Spain;
NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable
Ipsen Pharma
2011 - EUCTR2010-020742-10-ES Finland;Spain;Sweden;United Kingdom;
Neurology examination
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Neuropsychological Testing
The University of Texas Health Science Center at San Antonio
2001 Phase 3 NCT00134420 United States;
Niacin First
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2011 Phase 1/Phase 2 NCT01237041 United States;
None
Genexine, Inc.
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
NordiFlex
I-Mab Biopharma Co. Ltd.
2021 Phase 3 NCT04633057 China;
Nordilet®
Cinnagen
2016 Phase 3 NCT03223025 -
Norditropin
Lumos Pharma, Inc.
2021 Phase 2 EUCTR2020-000874-92-PL Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Novo Nordisk A/S
2017 Phase 3 NCT03075644 Japan;
Novo Nordisk Farma Oy
2009 Phase 4 EUCTR2008-001674-32-FI Finland;
VU University Medical Center
2013 - EUCTR2012-005066-36-NL Netherlands;
Norditropin FlexPro
Novo Nordisk A/S
2016 Phase 2 EUCTR2015-000531-32-BE Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-000290-39-GB Denmark;European Union;Japan;Sweden;United Kingdom;
2015 Phase 3 EUCTR2013-002892-16-LV Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2013-002892-16-LT Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-000290-39-DK Denmark;European Union;Japan;Sweden;United Kingdom;
2014 Phase 3 EUCTR2013-002892-16-SE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-002892-16-GB Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002892-16-DE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 - EUCTR2014-000290-39-SE Denmark;European Union;Japan;Sweden;United Kingdom;
Norditropin FlexPro 10 mg/1.5 ml
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Novo Nordisk A/S
2020 Phase 3 EUCTR2018-000231-27-PL Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-LV Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-HU Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-ES Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-EE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-SI Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-GB Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DK Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-AT Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-000531-32-SE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-DE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-SI Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-AT Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
- Phase 3 EUCTR2018-000231-27-NO Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-IE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-FR Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5 mg/1.5 mL
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5 mg/1.5 ml
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5mg/1.5 ml
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Norditropin Growth Hormone
Duke University
2007 - NCT00615953 United States;
Norditropin NordiFlex®
Novo Nordisk A/S
2012 Phase 1 NCT01706783 Denmark;Sweden;
2011 - NCT01327924 France;
Norditropin NordiFlex® 10 mg/1.5 ml
Novo Nordisk A/S
2009 Phase 2 EUCTR2008-008240-25-FR Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-ES Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-SI Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-GB Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-DK Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-BE Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
Norditropin NordiFlex® 10mg/1.5 ml
Novo Nordisk A/S
2009 Phase 2 EUCTR2008-008240-25-FR Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-ES Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-SI Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-GB Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-DK Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-BE Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
Norditropin SimpleXx
Karolinska universitetssjukhuset
2006 - EUCTR2005-004478-26-SE Sweden;
Novo Nordisk A/S
2014 Phase 1 EUCTR2013-000013-20-ES Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-SI Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-SE Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-BE Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-AT Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
- Phase 1 EUCTR2013-000013-20-FR Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
Norditropin SimpleXx (growth hormone)
Aarhus University Hospital
2010 Phase 2 NCT01090778 Denmark;
Norditropin SimpleXx 5mg/1.5ml
University of Birmingham
2005 - EUCTR2004-004835-72-GB United Kingdom;
Norditropin Simplex
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)
Endocrine Department, Sahlgrenska University Hospital
2005 - EUCTR2004-004292-11-SE Sweden;
Norditropin®
Novo Nordisk A/S
2021 Phase 3 NCT04970654 China;
2019 Phase 3 NCT03811535 Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Xiamen Amoytop Biotech Co., Ltd.
2018 Phase 2/Phase 3 NCT04513171 China;
Norditropin® FlexPro®
Novo Nordisk A/S
2019 - NCT03972345 Germany;
Norditropin® FlexPro® pen
Novo Nordisk A/S
2016 Phase 2 NCT02616562 Austria;Belgium;Brazil;France;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
Norditropin® SimpleXx® 5 mg/1.5ml
Medical Department M (Endocrinology & Diabetes)
2010 Phase 2 EUCTR2010-018586-39-DK Denmark;
NuSpin
Genentech, Inc.
2010 - NCT01243892 United States;
Nutritional supplementation standardized formula
Rabin Medical Center
2017 - NCT03053687 Israel;
Nutropin AQ
Children's Hospital Los Angeles
2004 Phase 4 NCT00140413 United States;
Oregon Health and Science University
2005 Phase 4 NCT00212758 United States;
The University of Texas Health Science Center at San Antonio
2001 Phase 3 NCT00134420 United States;
Nutropin Aq
CHU Amiens
2010 - EUCTR2010-019735-35-FR France;
NutropinAq
Beaufour Ipsen Pharma
2005 - EUCTR2004-000356-17-DK Denmark;Finland;Italy;
2005 - EUCTR2004-000356-17-AT Austria;Denmark;Finland;Italy;
CHU Amiens
2010 - EUCTR2010-019735-35-FR France;
Ipsen Scandinavia
2006 - EUCTR2004-000356-17-FI Denmark;Finland;Italy;
- Phase 4 EUCTR2004-000356-17-SE Austria;Denmark;Finland;Italy;Spain;Sweden;
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
NutropinAq 10 mg/2 ml
Ipsen Pharma
2011 - EUCTR2010-020742-10-SE Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-GB Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-FI Finland;Spain;Sweden;United Kingdom;
NutropinAq 10 mg/2 ml (30 UI)
Guillem Cuatrecasas Cambra
2012 Phase 2 EUCTR2011-005377-23-ES Spain;
OMNITROPE
ASCENDIS PHARMA A/S
2010 - EUCTR2010-021523-28-IT Austria;Denmark;Germany;Italy;Sweden;
Oestrogen
University of Aarhus
2001 - NCT00572390 Denmark;
Omnitrop
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Omnitrope
Ascendis Pharma A/S
2010 Phase 2 NCT01247675 Denmark;Germany;Italy;Sweden;
Omnitrope®
Ascendis Pharma A/S
2010 - EUCTR2010-021523-28-SE Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-DK Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-DE Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-AT Austria;Denmark;Germany;Italy;Sweden;
Once daily subcutaneous injection of Genotropin
Ascendis Pharma Endocrinology Division A/S
2016 Phase 3 NCT02781727 Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
Once weekly subcutaneous injection of TransCon hGH
Ascendis Pharma Endocrinology Division A/S
2016 Phase 3 NCT02781727 Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
Only medicinal products registered in Austria will be used in this clinical trial.
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Only medicinal products registered in Germany will be used in this clinical trial
ModigeneTech Ltd.
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Ophthalmologic evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Orthopedic evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
PEG-somatropin
GeneScience Pharmaceuticals Co., Ltd.
2017 Phase 4 NCT03290235 China;
2015 Phase 4 NCT03249480 China;
2015 Phase 4 NCT02976675 China;
2014 Phase 4 NCT02908958 China;
2014 Phase 4 NCT02380235 China;
2014 Phase 4 NCT02314676 China;
2007 Phase 3 NCT01495468 China;
PF-06836922
Pfizer Inc.
2019 Phase 3 EUCTR2018-000918-38-SK Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-GB Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-CZ Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-BG Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
PHA-794,428
PFIZER
2006 - EUCTR2005-005587-82-IT Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer
2006 - EUCTR2005-005587-82-NL Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Limited
2007 - EUCTR2005-005587-82-CZ Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2006 - EUCTR2005-005587-82-GB Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2006 - EUCTR2005-005587-82-DK Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Ltd
2007 Phase 2 EUCTR2005-005587-82-PL Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2007 - EUCTR2005-005587-82-GR Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer NV/SA
2006 - EUCTR2005-005587-82-BE Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Pharma GmbH
2006 - EUCTR2005-005587-82-DE Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
PHA-794428
Pfizer
2006 Phase 2 NCT00314938 Belgium;France;Germany;Israel;Spain;United Kingdom;
2006 Phase 2 NCT00308464 Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;
Pfizer Global Research and Development
2005 - EUCTR2005-001658-25-BE Belgium;
Pfizer Limited
2006 - EUCTR2005-005593-79-GB Germany;Spain;United Kingdom;
Pfizer N.V./S.A.
2006 - EUCTR2005-005593-79-BE Belgium;Germany;Spain;United Kingdom;
Pfizer Pharma GmbH
2006 - EUCTR2005-005593-79-DE Germany;Spain;United Kingdom;
Pfizer SA
2006 Phase 2 EUCTR2005-005593-79-ES Belgium;Germany;Spain;United Kingdom;
PN-180307
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2010 Phase 3 EUCTR2009-017354-12-SK Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-017354-12-GB Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-SE Czech Republic;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-DE Czech Republic;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-CZ Czech Republic;Germany;Sweden;United Kingdom;
- Phase 3 EUCTR2009-017354-12-NL Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
Pegvisomant
Oregon Health and Science University
2011 - NCT01804413 United States;
Pegylated Somatropin
GeneScience Pharmaceuticals Co., Ltd.
2006 Phase 2 NCT01342146 -
Pegylated polypeptide hormone of human recombinant origin PEG-hGH
Pfizer
2006 - EUCTR2005-005587-82-NL Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Limited
2007 - EUCTR2005-005587-82-CZ Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2006 - EUCTR2005-005593-79-GB Germany;Spain;United Kingdom;
2006 - EUCTR2005-005587-82-GB Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2006 - EUCTR2005-005587-82-DK Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Ltd
2007 Phase 2 EUCTR2005-005587-82-PL Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2007 - EUCTR2005-005587-82-GR Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer N.V./S.A.
2006 - EUCTR2005-005593-79-BE Belgium;Germany;Spain;United Kingdom;
Pfizer NV/SA
2006 - EUCTR2005-005587-82-BE Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Pharma GmbH
2006 - EUCTR2005-005593-79-DE Germany;Spain;United Kingdom;
2006 - EUCTR2005-005587-82-DE Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer SA
2006 Phase 2 EUCTR2005-005593-79-ES Belgium;Germany;Spain;United Kingdom;
Pegylated recombinant human growth hormone
Ambrx, Inc., USA
2008 - EUCTR2007-001746-40-HU Hungary;
Pegylated somatropin
GeneScience Pharmaceuticals Co., Ltd.
2010 Phase 1 NCT01613573 -
Phosphate sandoz
Royal Liverpool University hospital
2006 Phase 4 EUCTR2005-004316-73-GB United Kingdom;
Pioglitazone
University of Aarhus
2004 - NCT00459940 Denmark;
Plenadren 20 mg modified-release tablets
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark;
Plenadren 5 mg modified-release tablets
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark;
Polyethylene glycol
The Children's Hospital of Zhejiang University School of Medicine
2021 Phase 4 ChiCTR2100048579 China;
Psychiatric evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
R-Gene
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
R-Gene 10
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
R-hGH
Merck KGaA
2003 Phase 4 NCT01157793 -
R-hGH freeze-dried
EMD Serono
2008 Phase 1 NCT01034735 Germany;
R-hGH liquid (Saizen)
EMD Serono
2008 Phase 1 NCT01034735 Germany;
RECOMBINANT HUMAN SERUM ALBUMIN (HSA) FUSED TO HUMAN GROWTH HORMONE (HGH)
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-003796-32-PL Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-SI Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-HR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-GR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-DE Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-CZ Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-AT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-SK Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-RO Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-LT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-IT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-HU Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-ES Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-BG Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
RVG 15790 or RVG 25480
Radboud University Nijmegen Medical Centre, Department of Endocrinology
2006 Phase 4 EUCTR2006-001574-24-NL Netherlands;
Recombinanat DNA-derived human growth hormone produced in E.coli
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Recombinant DNA-derived human growth hormone
Ascendis Pharma A/S
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-GR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
Genexine, Inc.
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
Hanmi Pharmaceutical Co., Ltd.
2014 - EUCTR2011-001826-61-BG Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2012 - EUCTR2011-001826-61-PL Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2011 - EUCTR2011-001826-61-HU Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Prolor Biotech Ltd
2010 - EUCTR2010-019374-32-CZ Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
Recombinant DNA-derived human growth hormone produced in E.coli
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
OPKO Biologics Ltd.
2013 - EUCTR2011-004553-60-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 Phase 2 EUCTR2011-004553-60-HU Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 - EUCTR2011-004553-60-SK Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 - EUCTR2011-004553-60-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
PROLOR Biotech Ltd.
2012 - EUCTR2011-004553-60-GR Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
2012 - EUCTR2011-004553-60-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Recombinant Growth Hormone, Genotropin (Pfizer)
Federico II University
1996 - NCT00462475 Italy;
Recombinant Human Gowth Hormone
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Recombinant growth hormone
University Medical Center St Radboud, department of neurology
2007 - EUCTR2006-005442-37-NL Netherlands;
Recombinant human Growth Hormone (Genotropin® )
Charite University, Berlin, Germany
2003 Phase 4 NCT00929799 Germany;
Recombinant human Growth Hormone (rhGH)
Ascendis Pharma A/S
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Prolor Biotech Ltd
2010 - EUCTR2010-019374-32-CZ Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
Recombinant human Growth Hormone(rhGH)
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Recombinant human IGF-1
Columbia University
2008 - NCT00684957 United States;
Recombinant human growth hormone
EMD Serono
2005 Phase 3 NCT00109733 United States;
Huashan Hospital Affiliated to Fudan University
2020 Phase 0 ChiCTR2000039505 China;
Lumos Pharma, Inc.
2021 Phase 2 EUCTR2020-000874-92-PL Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Massachusetts General Hospital
2004 - NCT00182091 United States;
Sahlgrenska University Hospital
2010 - EUCTR2009-016783-37-SE Sweden;
Teva Branded Pharmaceutical Products R&D, Inc.
2013 Phase 2 NCT01811576 Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
The Children's Hospital of Zhejiang University School of Medicine
2021 Phase 4 ChiCTR2100048579 China;
The University of Texas Medical Branch, Galveston
2003 Phase 4 NCT00957671 United States;
Recombinant human growth hormone (r-hGH)
Merck KGaA
2007 Phase 4 NCT01187550 -
Recombinant human growth hormone (rhGH)
BioPartners GmbH
2015 Phase 3 EUCTR2005-000384-26-FR Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-002278-24-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-SE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-FR Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-ES Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-DE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-CZ Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-000346-36-LT Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 Phase 3 EUCTR2005-000384-26-SK Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2005-000384-26-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-SE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-DE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-CZ Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000346-36-SE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-FI Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-DE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
LG Life Science Ltd.
2005 - EUCTR2005-000384-26-ES Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-AT Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
LG Life Sciences Ltd.
2007 Phase 3 EUCTR2006-002278-24-SK Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-AT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
Recombinant human somatotropin
University of Milan
1995 - NCT00497484 Italy;
Recombinat human growth hormone
Versartis, Inc.
2015 Phase 3 EUCTR2014-004525-41-SE Belgium;Canada;Netherlands;Poland;Sweden;United States;
Regular insulin
Oregon Health and Science University
2011 - NCT01804413 United States;
RhGH Norditropin® pen (34 µg/kg)
Lumos Pharma
2020 Phase 2 NCT04614337 Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Routine transdermal oestrogen patch
University College, London
2016 - NCT02871986 United Kingdom;
SAIZEN
Merck KGaA
2013 Phase 4 EUCTR2012-004263-47-GB Australia;Czech Republic;Germany;Sweden;United Kingdom;
2013 Phase 4 EUCTR2012-004263-47-DE Australia;Czech Republic;Germany;Sweden;United Kingdom;
2013 - EUCTR2012-004263-47-SE Australia;Czech Republic;Germany;Sweden;United Kingdom;
2013 - EUCTR2012-004263-47-CZ Australia;Czech Republic;Germany;Sweden;United Kingdom;
SOMATROPIN (recombinant DNA-derived human growth hormone)
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
SOMATROPIN FOR INJECTION
OPKO Biologics Ltd.
2017 Phase 3 EUCTR2016-003874-42-GR Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-GB Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-ES Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-DE Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-BG Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-PL Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-FR Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Pfizer Inc.
2019 Phase 3 EUCTR2018-000918-38-SK Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-GB Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-CZ Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-BG Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Saizen
Merck KGaA, Darmstadt, Germany
2005 Phase 4 NCT00256126 Argentina;Australia;Austria;Canada;France;Germany;Italy;Norway;Russian Federation;Singapore;Spain;Sweden;United Kingdom;
Merck Serono Co., Ltd.
- - EUCTR2015-001569-20-Outside-EU/EEA China;
Merck Serono S.A.
2011 - EUCTR2010-023430-23-HU Czech Republic;Hungary;United Kingdom;
2011 - EUCTR2010-023430-23-GB Czech Republic;Hungary;United Kingdom;
2011 - EUCTR2010-023430-23-CZ Czech Republic;Hungary;United Kingdom;
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
University Federico II
2011 - EUCTR2009-017011-16-SE Sweden;
Saizen 8mg click.easy powder for solution for injection
Merck Serono S.A. Geneva
2011 - EUCTR2011-000460-10-CZ Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
Merck Serono SA
2011 - EUCTR2011-000460-10-GB Canada;Czech Republic;Italy;Russian Federation;Spain;United Kingdom;
Saizen 8mg click.easy power for solution for injection
Merck Serono S.A. Geneva
2011 Phase 4 EUCTR2011-000460-10-ES Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
Saizen®
EMD Serono
2010 Phase 3 NCT01237340 United States;
Saizen® solution for injection (referred as Saizen®)
Merck KGaA
2013 Phase 4 NCT01806298 Australia;Czech Republic;Germany;Sweden;United Kingdom;
Saline
Massachusetts General Hospital
2004 - NCT00182091 United States;
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group)
Centro Medico Teknon
2004 Phase 2 NCT00497562 Spain;
Sodium Chloride (NaCl) IV
Rabin Medical Center
2020 - NCT04465565 Israel;
Somapacitan
Novo Nordisk A/S
2022 - NCT05230550 Japan;
2021 Phase 3 NCT04970654 China;
2019 Phase 3 NCT03811535 Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 1 NCT03905850 Germany;
2017 Phase 3 NCT03075644 Japan;
2017 Phase 1 NCT03212131 Slovakia;
2017 Phase 1 NCT03186495 Germany;
2016 Phase 2 NCT02616562 Austria;Belgium;Brazil;France;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 NCT02382939 Denmark;France;Germany;Japan;Sweden;United Kingdom;
2014 Phase 3 NCT02229851 Australia;Brazil;Germany;India;Israel;Japan;Latvia;Lithuania;Malaysia;Norway;Poland;Romania;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 1 NCT01973244 Austria;Belgium;France;Israel;Macedonia, The Former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2012 Phase 1 NCT01706783 Denmark;Sweden;
2012 Phase 1 NCT01514500 Germany;
Somapacitan 10 mg/1.5ml PDS290
Novo Nordisk A/S
2020 Phase 3 EUCTR2018-000231-27-PL Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-LV Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-HU Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-ES Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-EE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-SI Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-GB Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DK Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-AT Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-NO Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-IE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-FR Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 10 mg/1.5ml PDS290S
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 15 mg/1.5ml PDS290
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Novo Nordisk A/S
2020 Phase 3 EUCTR2018-000231-27-PL Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-LV Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-HU Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-ES Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-EE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-SI Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-GB Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DK Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-AT Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-NO Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-IE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-FR Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 5 mg/1.5ml PDS290
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Novo Nordisk A/S
2020 Phase 3 EUCTR2018-000231-27-PL Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-LV Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-HU Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-ES Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-EE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-SI Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-GB Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DK Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-AT Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-NO Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-IE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-FR Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somatorelin
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
2004 - EUCTR2004-002125-42-IT Italy;
Somatostatin
University of Aarhus
2009 - NCT01062529 Denmark;
Somatotropin
Federico II University
2007 Phase 2 NCT01576861 Italy;
2004 Phase 2 NCT00591760 -
Somatotropine
Novo Nordisk Farma Oy
2009 Phase 4 EUCTR2008-001674-32-FI Finland;
Somatrogon
OPKO Biologics Ltd.
2017 Phase 3 EUCTR2016-003874-42-GR Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-GB Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-ES Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-DE Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-BG Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-PL Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-FR Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
PRM|21097
2017 Phase 3 EUCTR2016-003874-42-IT Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
Pfizer
2019 Phase 3 NCT03831880 Bulgaria;Czechia;Slovakia;United Kingdom;United States;
Pfizer Inc.
2019 Phase 3 EUCTR2018-000918-38-SK Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-GB Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-CZ Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-BG Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Somatrogon (Genetical Recombination)
OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
2017 Phase 3 JPRN-JapicCTI-183963 Japan;
Somatropin
ASCENDIS PHARMA A/S
2010 - EUCTR2010-021523-28-IT Austria;Denmark;Germany;Italy;Sweden;
Altus Pharmaceuticals
2009 Phase 2 NCT00837863 United States;
Ascendis Pharma Endocrinology Division A/S
2020 Phase 3 NCT04615273 Armenia;Australia;Canada;Georgia;Greece;Japan;Poland;Slovakia;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
BIOPARTNERS GMBH
2006 - EUCTR2005-000384-26-IT Czech Republic;Germany;Italy;Spain;Sweden;United Kingdom;
Beaufour Ipsen Pharma
2005 - EUCTR2004-000356-17-AT Austria;Denmark;Finland;Italy;
Beckert Michael
2021 Phase 3 JPRN-jRCT2051200129 Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
BioPartners GmbH
2015 Phase 3 EUCTR2005-000384-26-FR Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-002278-24-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-SE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-FR Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-ES Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-DE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-CZ Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-000346-36-LT Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 Phase 3 EUCTR2005-000384-26-SK Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2005-000384-26-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-SE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-DE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-CZ Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000346-36-SE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-FI Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-DE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
Daewoong Pharmaceutical Co. LTD.
2003 Phase 3 NCT02693522 Korea, Republic of;
Eli Lilly and Company
2004 Phase 3 NCT00191165 Italy;
2003 Phase 3 NCT00191360 Japan;
1999 Phase 4 NCT00490191 France;Germany;Italy;Puerto Rico;United Kingdom;United States;
1997 Phase 3 NCT00570011 United States;
Ferring Pharmaceuticals
2014 - NCT02018172 France;
2013 - NCT01731028 -
2007 - NCT01306357 France;
Ferring Pharmaceuticals A/S
2009 - EUCTR2008-004849-28-HU Hungary;
Genentech, Inc.
2015 Phase 4 NCT02311894 United States;
2010 - NCT01243892 United States;
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
HanAll BioPharma Co., Ltd.
2011 Phase 1 NCT01440686 Korea, Republic of;
Ioroi Minoru
2021 Phase 2 JPRN-jRCT2031210366 Japan;
2021 Phase 2 JPRN-jRCT2031200372 Japan;
Ipsen Pharma
2011 - EUCTR2010-020742-10-SE Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-GB Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-FI Finland;Spain;Sweden;United Kingdom;
Karolinska universitetssjukhuset
2006 - EUCTR2005-004478-26-SE Sweden;
L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
2013 Phase 1 NCT01494779 Brazil;
LG Life Science Ltd.
2005 - EUCTR2005-000384-26-ES Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-AT Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
LG Life Sciences
2016 Phase 4 NCT03015909 Korea, Republic of;
LG Life Sciences Ltd.
2007 Phase 3 EUCTR2006-002278-24-SK Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-AT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
Massachusetts General Hospital
2002 - NCT00136032 United States;
Merck Serono S.A. Geneva
2011 Phase 4 EUCTR2011-000460-10-ES Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
2011 - EUCTR2011-000460-10-CZ Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
Merck Serono SA
2011 - EUCTR2011-000460-10-GB Canada;Czech Republic;Italy;Russian Federation;Spain;United Kingdom;
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Novo Nordisk A/S
2015 Phase 3 NCT02382939 Denmark;France;Germany;Japan;Sweden;United Kingdom;
2015 Phase 3 EUCTR2014-000290-39-GB Denmark;European Union;Japan;Sweden;United Kingdom;
2015 Phase 3 EUCTR2013-002892-16-LV Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2013-002892-16-LT Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-000290-39-DK Denmark;European Union;Japan;Sweden;United Kingdom;
2014 Phase 3 NCT02229851 Australia;Brazil;Germany;India;Israel;Japan;Latvia;Lithuania;Malaysia;Norway;Poland;Romania;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002892-16-SE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-002892-16-GB Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002892-16-DE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 - EUCTR2014-000290-39-SE Denmark;European Union;Japan;Sweden;United Kingdom;
2013 Phase 1 NCT01973244 Austria;Belgium;France;Israel;Macedonia, The Former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2009 Phase 2 NCT00936403 Belgium;Czech Republic;Denmark;France;Israel;Macedonia, The Former Yugoslav Republic of;Slovenia;Spain;Turkey;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-FR Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-ES Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 - NCT01109017 Japan;
2009 - NCT00934063 Germany;
2009 - EUCTR2008-008240-25-SI Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-GB Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-DK Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-BE Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2006 - NCT00960128 Argentina;Belgium;Brazil;Czech Republic;Czechia;Denmark;Finland;Former Serbia and Montenegro;France;Germany;Hungary;Ireland;Israel;Italy;Lithuania;Luxembourg;Netherlands;Norway;Russian Federation;Saudi Arabia;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2005 - NCT01604161 Japan;
2004 Phase 3 NCT00184730 Japan;
2003 Phase 4 NCT00567385 Turkey;
2003 Phase 3 NCT00519558 Japan;
2003 Phase 3 NCT00184743 Japan;
2003 - NCT01580605 France;
2003 - NCT01543880 Germany;
2002 Phase 3 NCT00184678 Australia;Austria;Belgium;France;Germany;Hungary;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2002 - NCT01009905 United States;
2001 Phase 4 NCT01698944 Greece;
2001 Phase 3 NCT01502124 United States;
2001 - NCT01543867 Germany;
2000 Phase 3 NCT01563926 Israel;
2000 Phase 3 NCT00262249 United States;
2000 Phase 1 NCT00931476 United States;
1998 Phase 4 NCT01562834 France;
OPKO Biologics Ltd.
2013 - EUCTR2011-004553-60-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 Phase 2 EUCTR2011-004553-60-HU Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 - EUCTR2011-004553-60-SK Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 - EUCTR2011-004553-60-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
2017 Phase 3 JPRN-JapicCTI-183963 Japan;
OPKO Health, Inc.
2016 Phase 3 NCT02968004 Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;Georgia;Germany;Greece;India;Israel;Italy;Korea, Republic of;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2012 Phase 2 NCT01592500 Greece;Hungary;Slovakia;
PRM|21097
2017 Phase 3 EUCTR2016-003874-42-IT Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
PROLOR Biotech Ltd.
2012 - EUCTR2011-004553-60-GR Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
2012 - EUCTR2011-004553-60-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Pfizer
2008 Phase 3 NCT00630487 Germany;
2007 - NCT00601419 -
2005 Phase 3 NCT00163189 France;
1997 Phase 3 NCT00174278 France;
Pfizer Pharma GmbH
2008 - EUCTR2007-000790-36-DE Germany;
Prolor Biotech Ltd
2010 - EUCTR2010-019374-32-CZ Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
Teva Pharmaceutical Industries, Ltd.
2014 Phase 2 NCT02092077 Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
The Children's Hospital, Zhejiang University School of Medicine
2018 - ChiCTR1800017144 China‘;
University of Birmingham
2005 - EUCTR2004-004835-72-GB United Kingdom;
VA Office of Research and Development
2022 Phase 3 NCT04867317 United States;
Somatropin (INN) recombinant DNA orgin, Escherichia coli
Beaufour Ipsen Pharma
2005 - EUCTR2004-000356-17-DK Denmark;Finland;Italy;
Somatropin (rDNA origin)
Eli Lilly and Company
2002 - NCT01088399 -
Somatropin (recombinant DNA origin produced in E. coli)
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Somatropin AQ
GeneScience Pharmaceuticals Co., Ltd.
2010 Phase 1 NCT01613573 -
Somatropin Injection
GeneScience Pharmaceuticals Co., Ltd.
2017 Phase 2 NCT03104010 China;
Somatropin injection
Nemours Children's Clinic
2019 - NCT04020913 United States;
Somatropina
Pfizer, S.A
2007 Phase 4 EUCTR2007-003586-41-ES France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Somatropine
Sanofi
2003 Phase 3 NCT00476385 France;
Somavaratan
Versartis Inc.
2017 Phase 3 NCT03145831 Japan;United States;
2016 Phase 2 NCT02719990 Australia;United States;
2015 Phase 3 NCT02339090 Belgium;Canada;Netherlands;Poland;Sweden;United States;
2015 Phase 2 NCT02526420 Australia;Germany;United Kingdom;United States;
2015 Phase 2 EUCTR2015-002072-24-DE Australia;Germany;United Kingdom;United States;
2014 Phase 2/Phase 3 NCT02068521 United States;
Versartis, Inc.
2017 Phase 3 EUCTR2016-002780-34-PL Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2016-002780-34-SE Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2016-002780-34-BE Belgium;Canada;Poland;Sweden;United States;
Somavaratan (VRS-317)
Versartis Inc.
2015 Phase 2/Phase 3 NCT02413138 Japan;
Versartis, Inc.
2015 Phase 3 EUCTR2014-004525-41-SE Belgium;Canada;Netherlands;Poland;Sweden;United States;
Speech pathology evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Sterile Water for Injection
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Strontium ranelate
Royal Liverpool University hospital
2006 Phase 4 EUCTR2005-004316-73-GB United Kingdom;
Sustained release growth hormone
BIOPARTNERS GMBH
2007 - EUCTR2006-002278-24-IT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
Sustained-release recombinant human GH (SR-rhGH)
LG Life Sciences
2009 Phase 4 NCT01605331 -
Synacthen
Cardiff University
2008 Phase 4 EUCTR2007-000056-14-GB United Kingdom;
University of Wuerzburg
2005 - NCT00552487 Germany;
Synacthen (Tetracosactrin)
Cardiff University
2008 Phase 4 NCT00851942 United Kingdom;
Syntropin
Phage Pharmaceuticals, Inc.
2004 Phase 1 NCT00489294 United States;
TJ101
I-Mab Biopharma Co. Ltd.
2021 Phase 3 NCT04633057 China;
TRANSCON PEG40 HGH
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003410-20-PL Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-IT Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-GR Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-BG Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
TRANSCON PEG40 HGH, Transiently PEGylated hGH prodrug
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TV-1106
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 3 NCT02410356 Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 NCT02410343 Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2013 Phase 2 NCT01811576 Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-003796-32-PL Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-SI Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-HR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-GR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-DE Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-CZ Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-AT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-SK Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-RO Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-LT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-IT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-HU Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-ES Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-BG Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2013 Phase 2 EUCTR2012-004975-37-DE Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SK Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SI Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-SE Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-HU Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-GR Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-CZ Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 NCT02092077 Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
TV1106
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Tesamorelin
Columbia University
2018 Phase 4 NCT03226821 United States;
Testogel
Dr. Chris Thompson
2006 - EUCTR2005-005613-38-IE Ireland;
Testosterone plus somatropin
University of Pennsylvania
2004 Phase 2 NCT00080483 United States;
TheraDerm
Massachusetts General Hospital
2001 - NCT00027430 United States;
Thyroxin, Triiodothyronine
University Hospital Freiburg
2004 Phase 4 NCT00360074 Germany;
Tiratricol
Rare Thyroid Therapeutics International
2020 Phase 2 EUCTR2019-003370-35-IT Czech Republic;Czechia;France;Germany;Italy;Netherlands;United Kingdom;United States;
TransCon hGH
Ascendis Pharma A/S
2017 Phase 3 NCT03344458 Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;New Zealand;Poland;Russian Federation;Ukraine;United States;
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 NCT03305016 Australia;Canada;New Zealand;United States;
Visen Pharmaceuticals (Shanghai) Co., Ltd.
2019 Phase 3 NCT04326374 China;
TransCon hGH (ACP-011)
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2017-003410-20-PL Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-IT Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-GR Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-BG Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH (ACP-011) -
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH (ACP-011) - 12,
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH CT-301 (ACP-011) - 12,
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Transdermal Testosterone gel
Charles Drew University of Medicine and Science
2003 Phase 4 NCT00144391 United States;
Transiently PEGylated hGH prodrug
Ascendis Pharma A/S
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-GR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Trisequens
Dr. Chris Thompson
2006 - EUCTR2005-005613-38-IE Ireland;
VRS-317
Versartis Inc.
2015 Phase 2 EUCTR2015-002072-24-DE Australia;Germany;United Kingdom;United States;
2011 Phase 1 NCT01359488 United States;
Versartis, Inc.
2017 Phase 3 EUCTR2016-002780-34-PL Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2016-002780-34-SE Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2016-002780-34-BE Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2014-004525-41-PL Belgium;Canada;Netherlands;Poland;Sweden;United States;
2015 Phase 3 EUCTR2014-004525-41-BE Belgium;Canada;Netherlands;Poland;Sweden;United States;
2015 - EUCTR2014-004525-41-NL Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States;
Y-shape pegylated somatropin
Xiamen Amoytop Biotech Co., Ltd.
2018 Phase 2/Phase 3 NCT04513171 China;
ZD1033
Nemours Children's Clinic
- - EUCTR2012-001183-30-Outside-EU/EEA United States;
Zomacton
Ferring Pharmaceuticals
2018 - NCT03274973 Germany;
2010 Phase 3 NCT00884000 Hungary;India;Israel;Poland;Romania;Russian Federation;Ukraine;
VU University Medical Center
2013 - EUCTR2012-005066-36-NL Netherlands;
Zomacton 10 mg/ml
Ferring Pharmaceuticals A/S
2009 - EUCTR2008-004849-28-HU Hungary;
ASCENDIS PHARMA A/S
2010 - EUCTR2010-021523-28-IT Austria;Denmark;Germany;Italy;Sweden;
Ascendis Pharma A/S
2013 Phase 2 NCT01947907 Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-GR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2010 - EUCTR2010-021523-28-SE Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-DK Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-DE Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-AT Austria;Denmark;Germany;Italy;Sweden;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
ACP-001 (TransCon hGH)
Ascendis Pharma A/S
2010 Phase 2 NCT01247675 Denmark;Germany;Italy;Sweden;
ACP-011
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
AEZS-130
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002337-22-IT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
2016 Phase 3 EUCTR2015-002337-22-PL Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
2016 Phase 3 EUCTR2015-002337-22-DE Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002337-22-GB Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-002337-22-AT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
AEZS-130 (formerly ARD-07)
AEterna Zentaris
2007 Phase 3 NCT00448747 United States;
AGUA PARA PREPARACIONES INYECTABLES
Ipsen Pharma
2011 - EUCTR2010-020742-10-ES Finland;Spain;Sweden;United Kingdom;
ALRN-5281
Aileron Therapeutics
2013 Phase 1 NCT01775358 United States;
ALTU-238
Altus Pharmaceuticals
2005 Phase 2 NCT00297713 United States;
ARGININA CLORIDRATO
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
ARX201
Ambrx, Inc.
2008 Phase 2 NCT00778518 Hungary;
Ambrx, Inc., USA
2008 - EUCTR2007-001746-40-HU Hungary;
Acipimox
University of Aarhus
2016 - NCT02782208 Denmark;
2012 - NCT01209416 Denmark;
Albutropin
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-003796-32-PL Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-SI Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-HR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-GR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-DE Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-CZ Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-AT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-SK Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-RO Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-LT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-IT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-HU Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-ES Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-BG Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2013 Phase 2 EUCTR2012-004975-37-DE Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SK Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SI Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-SE Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-HU Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-GR Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-CZ Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Amitriptyline, fluoxetine and tramadol alone (control group)
Centro Medico Teknon
2004 Phase 2 NCT00497562 Spain;
Arg
Merck KGaA
2004 Phase 3 NCT01060488 France;
Arginin
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Arginine
AEterna Zentaris
2021 Phase 3 NCT04786873 United States;
Helsinki University Central Hospital
2001 - NCT03018886 Finland;
Osaka City University Graduate School of Medicine
2017 - JPRN-UMIN000027260 Japan;
Arginine and Clonidine Stimulation Testing
The University of Texas Health Science Center at San Antonio
2001 Phase 3 NCT00134420 United States;
Arginine stimulation test after each limb
Christie Hospital NHS Foundation Trust
2004 - NCT00468624 United Kingdom;
Aricept
Ludwig Boltzmann Gesellschaft
2006 - EUCTR2005-001315-22-AT Austria;
Arimidex
Nemours Children's Clinic
- - EUCTR2012-001183-30-Outside-EU/EEA United States;
Arimidex (Anastrozole)
Nemours Children's Clinic
2001 Phase 2/Phase 3 NCT00133354 United States;
Audiological and ear, nose and throat examination
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
BPLG-003
BioPartners GmbH
2003 Phase 2/Phase 3 NCT00600808 -
Behavior and neuropsychometric evaluations
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Biopsy
University Hospital, Toulouse
2009 Phase 4 NCT01298180 France;
Blood draws
Columbia University
2007 - NCT00720902 United States;
Blood sampling before
Christie Hospital NHS Foundation Trust
2004 - NCT00468624 United Kingdom;
Byetta
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
2021 Phase 2 EUCTR2020-004115-27-ES Spain;
CLONIDINA CLORIDRATO
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
CLONIDINE HYDROCHLORIDE
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Carotid ultrasound
Columbia University
2007 - NCT00720902 United States;
Catapresan
Centre for Human Drug Research
2007 - EUCTR2006-003678-82-NL Netherlands;
Catapresan 75
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
Change in daily dosage of Growth Hormone
VU University Medical Center
2013 Phase 4 NCT01877512 Netherlands;
Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001)
Hanmi Pharmaceutical Co., Ltd.
2014 - EUCTR2011-001826-61-BG Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2012 - EUCTR2011-001826-61-PL Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2011 - EUCTR2011-001826-61-HU Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
CinnaTropin®
Cinnagen
2016 Phase 3 NCT03223025 -
Clonidin
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Clonidine
AEterna Zentaris
2021 Phase 3 NCT04786873 United States;
Clonidine HCl CF 0,150 mg, tabletten
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Corticotropin
Max-Planck-Institute of Psychiatry
2008 - NCT00666068 Germany;
DEXA, blood tests, H.G.P.O, osseous age.
University Hospital, Toulouse
2009 Phase 4 NCT01298180 France;
DGH
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 3 NCT02410356 Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Daily hGH
Visen Pharmaceuticals (Shanghai) Co., Ltd.
2019 Phase 3 NCT04326374 China;
Daily rhGH
Versartis Inc.
2015 Phase 3 NCT02339090 Belgium;Canada;Netherlands;Poland;Sweden;United States;
Dental evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Determination of growth hormone status
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Dextromethorphan and Caffeine
University of Louisville
2001 - NCT00458991 United States;
Donepezil
Ludwig Boltzmann Gesellschaft
2006 - EUCTR2005-001315-22-AT Austria;
Dose-Establishing Study 1 Niacin
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2011 Phase 1/Phase 2 NCT01237041 United States;
Dose-Establishing Study 2 Niacin
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2011 Phase 1/Phase 2 NCT01237041 United States;
Dysmorphology evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Ecombinanat DNA-derived human growth h
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Emcitate
Rare Thyroid Therapeutics International
2020 Phase 2 EUCTR2019-003370-35-IT Czech Republic;Czechia;France;Germany;Italy;Netherlands;United Kingdom;United States;
Rare Thyroid Therapeutics International AB
2020 Phase 2 EUCTR2019-003370-35-GB Czech Republic;France;Germany;Italy;Netherlands;United Kingdom;United States;
Endothelial cell biopsy
Columbia University
2007 - NCT00720902 United States;
Eutropin
Daewoong Pharmaceutical Co. LTD.
2003 Phase 3 NCT02693522 Korea, Republic of;
Experimental: CRH administration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2021 Phase 4 NCT04902235 Spain;
Experimental: GLP1-RA (exenatide) administration
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2021 Phase 4 NCT04897802 Spain;
Experimental: VRS-317
Versartis Inc.
2012 Phase 1/Phase 2 NCT01718041 United States;
Fat diet
University Hospital Inselspital, Berne
2011 - NCT01467193 Switzerland;
GENOTROPIN 12 mg powder and solvent for solution for injection.
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
GH sampling - every 20 min over 24 hours
Christie Hospital NHS Foundation Trust
2004 - NCT00468624 United Kingdom;
GH substitution
University of Aarhus
2016 - NCT02782208 Denmark;
GHRH
Helsinki University Central Hospital
2001 - NCT03018886 Finland;
Merck KGaA
2004 Phase 3 NCT01060488 France;
GHRH/arginine stimulation testing
Children's Mercy Hospital Kansas City
2007 - NCT00324064 United States;
GX-H9
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
Genexine, Inc.
2016 Phase 2 NCT03309891 Ukraine;
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 NCT02946606 Korea, Republic of;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
Gastrointestinal evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Gelatin
Top Institute Food and Nutrition
- - EUCTR2010-018781-23-NL Netherlands;
Genotonorm Kabipen 5.3 mg polvo y disolvente para sol. inyectable (Marca internacional Genotropin)
Pfizer, S.A
2007 Phase 4 EUCTR2007-003586-41-ES France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotonorm Kabipen 5.3 mg polvo y disolvente para solución inyectable (Marca internacional Genotropin)
Pfizer, S.A
2007 Phase 4 EUCTR2007-003586-41-ES France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotropin
Ascendis Pharma A/S
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-GR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
BioPartners GmbH
2006 - EUCTR2005-000346-36-LT Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-SE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-FI Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-DE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
Cristália Produtos Químicos Farmacêuticos Ltda.
- - EUCTR2016-000446-56-Outside-EU/EEA Brazil;
Ferring Pharmaceuticals
2010 Phase 3 NCT00884000 Hungary;India;Israel;Poland;Romania;Russian Federation;Ukraine;
Genexine, Inc.
2016 Phase 2 NCT03309891 Ukraine;
2015 Phase 2 NCT02946606 Korea, Republic of;
Hanmi Pharmaceutical Co., Ltd.
2014 - EUCTR2011-001826-61-BG Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2012 - EUCTR2011-001826-61-PL Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2011 - EUCTR2011-001826-61-HU Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
Hanmi Pharmaceutical Company Limited
2011 Phase 2 NCT01822340 Hungary;Romania;
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
OPKO Biologics Ltd.
2017 Phase 3 EUCTR2016-003874-42-GR Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-GB Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-ES Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-DE Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-BG Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004553-60-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 Phase 2 EUCTR2011-004553-60-HU Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 - EUCTR2011-004553-60-SK Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 - EUCTR2011-004553-60-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
- Phase 3 EUCTR2016-003874-42-PL Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-FR Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
2017 Phase 3 JPRN-JapicCTI-183963 Japan;
OPKO Health, Inc.
2017 Phase 3 NCT03874013 Japan;
PFIZER
2008 - EUCTR2007-003586-41-IT France;Italy;Netherlands;Spain;Sweden;United Kingdom;
PRM|21097
2017 Phase 3 EUCTR2016-003874-42-IT Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
PROLOR Biotech Ltd.
2012 - EUCTR2011-004553-60-GR Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
2012 - EUCTR2011-004553-60-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Pfizer
2019 Phase 3 NCT03831880 Bulgaria;Czechia;Slovakia;United Kingdom;United States;
2008 Phase 4 NCT00555009 France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2007 - EUCTR2007-003586-41-SE France;Italy;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003586-41-NL France;Italy;Netherlands;Spain;Sweden;United Kingdom;
2007 - EUCTR2007-003586-41-GB France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Radboud University Nijmegen Medical Centre, Department of Endocrinology
2006 Phase 4 EUCTR2006-001574-24-NL Netherlands;
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
VU University Medical Center
2013 - EUCTR2012-005066-36-NL Netherlands;
Genotropin (PN-180,307) Somatropin
Pfizer
2007 Phase 4 NCT00432263 -
Genotropin 12 mg/ml
Ferring Pharmaceuticals A/S
2009 - EUCTR2008-004849-28-HU Hungary;
Genotropin 5 mg/ml
Pfizer Pharma GmbH
2008 - EUCTR2007-000790-36-DE Germany;
Genotropin 5.3 mg in injection system Genotropin pen
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2010 Phase 3 EUCTR2009-017354-12-SK Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
Genotropin GoQuick
Pfizer Inc.
2019 Phase 3 EUCTR2018-000918-38-SK Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-GB Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-CZ Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-BG Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Genotropin Mark VII pen
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2010 Phase 3 EUCTR2009-017354-12-SK Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-017354-12-GB Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-SE Czech Republic;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-DE Czech Republic;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-CZ Czech Republic;Germany;Sweden;United Kingdom;
- Phase 3 EUCTR2009-017354-12-NL Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
Genotropin MiniQuick
Dr. Chris Thompson
2006 - EUCTR2005-005613-38-IE Ireland;
Genotropin Miniqu
Amar Agha, Beaumont Hospital
2009 - EUCTR2009-010918-30-IE Ireland;
Genotropin Miniquick
Amar Agha, Beaumont Hospital
2009 - EUCTR2009-010918-30-IE Ireland;
Genotropin miniquick 0.5 mg, injection
University of Aarhus
2019 - NCT03878992 Denmark;
Genotropin, Genotropin MiniQuick
Sahlgrenska University Hospital
2010 - EUCTR2009-016783-37-SE Sweden;
Genotropin/GENOTONORM®
Pfizer Ltd. Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2008 - EUCTR2007-003586-41-FR France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Genotropin®
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
Genexine, Inc.
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
Teva Pharmaceutical Industries Ltd.
2013 Phase 2 EUCTR2012-004975-37-DE Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SK Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SI Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-SE Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-HU Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-GR Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-CZ Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Ghrelin
University of Aarhus
2012 - NCT01209416 Denmark;
Glucagon stimulation test and insulin tolerance test
The Cleveland Clinic
2011 - NCT01282164 United States;
Growth Factors Laboratory Testing
The University of Texas Health Science Center at San Antonio
2001 Phase 3 NCT00134420 United States;
Growth Hormone Replacement Therapy
University of Liverpool
2014 - NCT02243852 United Kingdom;
Growth Hormone, GH
University of Birmingham
2005 - EUCTR2004-004835-72-GB United Kingdom;
Growth Hormone-Releasing Hormone
Stefania La Grutta, MD
2014 - NCT02507245 -
Growth hormone
Columbia University
2017 - NCT03225755 United States;
Ferring Pharmaceuticals
2007 - NCT01365351 Germany;
LG Life Sciences
2006 Phase 3 NCT00294619 United States;
National Center for Research Resources (NCRR)
1997 - NCT00006394 United States;
Ohio State University
2005 Phase 4 NCT00373386 United States;
Royal Liverpool University hospital
2006 Phase 4 EUCTR2005-004316-73-GB United Kingdom;
University Hospital, Angers
2005 - NCT00187993 France;
University of Palermo
2016 - NCT03203356 Italy;
Growth hormone (Genotonorm® or Omnitrope®)
University Hospital, Toulouse
2009 Phase 4 NCT01298180 France;
Growth hormone (Genotropin)
Oregon Health and Science University
2006 Phase 0 NCT00517062 United States;
Growth hormone (Nutropin)
Baylor College of Medicine
2006 - NCT00362063 United States;
Growth hormone (genotropin)
University of Aarhus
2008 - NCT00646815 Denmark;
Growth hormone (somatropin)
LG Life Sciences
2005 Phase 3 NCT00271518 United States;
Growth hormone - LB03002
LG Life Sciences
2006 Phase 3 NCT00596037 United States;
Growth hormone administration for 6 months
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2005 - NCT00149708 Brazil;
Growth hormone releasing hormone (GHRH) 1-44
Massachusetts General Hospital
2008 Phase 2 NCT00675506 United States;
Growth hormone releasing hormone (GHRH) and arginine
Columbia University
2007 - NCT00720902 United States;
Growth hormone replacement therapy in growth hormone deficient patients only.
University Hospital Inselspital, Berne
2007 - NCT00491582 Switzerland;
H01AC01
Sahlgrenska University Hospital
2010 - EUCTR2009-016783-37-SE Sweden;
HGH
Beckert Michael
2021 Phase 3 JPRN-jRCT2051200129 Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
2021 Phase 3 JPRN-jRCT2031200340 Japan;
HGH-ViaDerm™ System (hGH or somatropin)
Teva Neuroscience, Inc.
2007 Phase 1 NCT00455260 Israel;Ukraine;
HGH-hyFc, recombinant human growth hormone
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
Genexine, Inc.
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
HM10560A
Hanmi Pharmaceutical Co., Ltd.
2014 - EUCTR2011-001826-61-BG Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2012 - EUCTR2011-001826-61-PL Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2011 - EUCTR2011-001826-61-HU Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
Hanmi Pharmaceutical Company Limited
2011 Phase 2 NCT01822340 Hungary;Romania;
HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH)
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Humalog Mix50 100 U/ml sospensione iniettabile
AETERNA ZENTARIS GMBH
2016 Phase 3 EUCTR2015-002337-22-IT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Human Growth Hormone (1-134)
Stanford University
2009 Phase 3 NCT01007071 United States;
Human Serum Albumin (HSA) fused to somatropin
Teva Pharmaceutical Industries Ltd.
2013 Phase 2 EUCTR2012-004975-37-DE Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SK Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SI Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-SE Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-HU Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-GR Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-CZ Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Human acylated ghrelin
University of Aarhus
2005 - NCT00139945 Denmark;
Human growth hormone
Federico II University
2019 Phase 3 NCT03775993 -
Humatrope
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
VU University Medical Center
2013 - EUCTR2012-005066-36-NL Netherlands;
Humatrope® 6 mg, powder and solvent for solution for injection
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Hydrocortisone
Amar Agha
2008 - EUCTR2007-005018-37-IE Ireland;
University Hospital Inselspital, Berne
2015 - NCT02360046 Switzerland;
Hydrocortisone TAKEDA, tabletter
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark;
Hydrocortone
Amar Agha
2008 - EUCTR2007-005018-37-IE Ireland;
Bradford Teaching Hospitals NHS Foundation Trust
2004 Phase 4 EUCTR2004-002056-34-GB United Kingdom;
Hydrokortison Glostrup
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark;
INCRELEX 10 mg/ml
Ipsen Pharma
2011 - EUCTR2010-020742-10-SE Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-GB Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-FI Finland;Spain;Sweden;United Kingdom;
INCRELEX 10 mg/ml, solución inyectable
Ipsen Pharma
2011 - EUCTR2010-020742-10-ES Finland;Spain;Sweden;United Kingdom;
Insulin
AETERNA ZENTARIS GMBH
2016 Phase 3 EUCTR2015-002337-22-IT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
AEterna Zentaris
2015 Phase 3 NCT02558829 Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Intravenous Infusion of Diclofenac Sodium
Azienda Ospedaliera Città della Salute e della Scienza di Torino
2021 Phase 4 NCT05188131 Italy;
Jintropin AQ
GeneScience Pharmaceuticals Co., Ltd.
2006 Phase 2 NCT01342146 -
L-ARG+GHRH
AEterna Zentaris
2007 Phase 3 NCT00448747 United States;
LB03002
BIOPARTNERS GMBH
2007 - EUCTR2006-002278-24-IT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-000384-26-IT Czech Republic;Germany;Italy;Spain;Sweden;United Kingdom;
BioPartners GmbH
2015 Phase 3 EUCTR2005-000384-26-FR Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-002278-24-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-SE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-FR Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-ES Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-DE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-CZ Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-000346-36-LT Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 Phase 3 EUCTR2005-000384-26-SK Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2005-000384-26-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-SE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-DE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-CZ Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000346-36-SE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-FI Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-DE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
LG Life Science Ltd.
2005 - EUCTR2005-000384-26-ES Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-AT Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
LG Life Sciences Ltd.
2007 Phase 3 EUCTR2006-002278-24-SK Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-AT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
LUM-201
Lumos Pharma
2022 Phase 2 NCT05250063 United States;
2021 Phase 2 NCT04806854 Chile;
2020 Phase 2 NCT04614337 Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Lumos Pharma, Inc.
2021 Phase 2 EUCTR2020-000874-92-PL Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Levothyroxine
Christie Hospital NHS Trust
2005 - EUCTR2004-005184-15-GB United Kingdom;
Rigshospitalet, Denmark
2012 - NCT01574859 Denmark;
Lonapegsomatropin
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 NCT05171855 United States;
2020 Phase 3 NCT04615273 Armenia;Australia;Canada;Georgia;Greece;Japan;Poland;Slovakia;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-PL Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-IT Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-GR Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-BG Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Beckert Michael
2021 Phase 3 JPRN-jRCT2051200129 Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
2021 Phase 3 JPRN-jRCT2031200340 Japan;
Lonapegsomatropin drug product
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Long-Acting Growth Hormone (LAGH)
University of Minnesota
2021 - NCT04938466 United States;
MACIMORELIN ACETATE
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
2019 Phase 2 EUCTR2018-001988-23-PL Belarus;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2018 Phase 2 EUCTR2018-001988-23-HU Hungary;Poland;Russian Federation;Serbia;Ukraine;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
MOD-4023
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
OPKO Biologics Ltd.
2017 Phase 3 EUCTR2016-003874-42-GR Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-GB Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-ES Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-DE Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-BG Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-000830-37-PL Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-000830-37-NL Austria;France;Germany;Greece;Hungary;Israel;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-SK Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-HU Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-GB Armenia;Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-AT Australia;Austria;France;Georgia;Germany;Greece;Hungary;Israel;Korea, Republic of;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Taiwan;Ukraine;United Kingdom;United States;
2013 - EUCTR2011-004553-60-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 Phase 2 EUCTR2011-004553-60-HU Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 - EUCTR2011-004553-60-SK Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 - EUCTR2011-004553-60-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
- Phase 3 EUCTR2016-003874-42-PL Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-FR Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
OPKO Health, Inc.
2017 Phase 3 NCT03874013 Japan;
2016 Phase 3 NCT02968004 Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;Georgia;Germany;Greece;India;Israel;Italy;Korea, Republic of;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 1 NCT02418767 United States;
2013 Phase 3 NCT01909479 Israel;United States;
2013 Phase 2 NCT02500316 Belarus;Greece;Hungary;Russian Federation;Slovakia;Ukraine;United States;
2012 Phase 2 NCT01592500 Greece;Hungary;Slovakia;
2010 Phase 2 NCT01225666 Czech Republic;Czechia;Hungary;Israel;Serbia;Slovakia;Slovenia;
PRM|21097
2017 Phase 3 EUCTR2016-003874-42-IT Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
PROLOR Biotech Ltd.
2013 Phase 3 EUCTR2013-000830-37-GR Austria;France;Germany;Greece;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2013 Phase 3 EUCTR2013-000830-37-ES Austria;France;Germany;Greece;Hungary;Israel;Italy;Netherlands;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Ukraine;United Kingdom;United States;
2012 - EUCTR2011-004553-60-GR Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
2012 - EUCTR2011-004553-60-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Prolor Biotech Ltd
2010 - EUCTR2010-019374-32-CZ Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
MRI
Columbia University
2007 - NCT00720902 United States;
Macimorelin
AEterna Zentaris
2021 Phase 3 NCT04786873 United States;
2015 Phase 3 NCT02558829 Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Macimorelin Consilient Health
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
Macimorelin acetate
AETERNA ZENTARIS GMBH
2016 Phase 3 EUCTR2015-002337-22-IT Austria;France;Germany;Italy;Poland;Serbia;Spain;United Kingdom;United States;
Macimorelina
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Macrilen
Aeterna Zentaris GmbH
2019 Phase 2 EUCTR2018-001988-23-PL Belarus;Hungary;Poland;Russian Federation;Serbia;Ukraine;
2018 Phase 2 EUCTR2018-001988-23-HU Hungary;Poland;Russian Federation;Serbia;Ukraine;
Magnetic resonance imaging of the brain
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Measurement of growth, thyroid and sex hormone levels
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Mecasermin
Ipsen Pharma
2011 - EUCTR2010-020742-10-SE Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-GB Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-FI Finland;Spain;Sweden;United Kingdom;
NDC0009-0436-01
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
NN-220
Novo Nordisk A/S
- Phase 3 EUCTR2017-000914-47-Outside-EU/EEA Japan;
NN8630
Novo Nordisk A/S
2008 - EUCTR2008-001061-29-DK Denmark;
NN8640
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
NNC 126-0083
Novo Nordisk A/S
2009 Phase 2 EUCTR2008-008240-25-FR Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-ES Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-SI Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-GB Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-DK Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-BE Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2008 - EUCTR2008-001061-29-DK Denmark;
NNC0195-0092 10 mg/1.5 ml PDS290-10
Novo Nordisk A/S
2016 Phase 2 EUCTR2015-000531-32-SE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-DE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-BE Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-SI Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-AT Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 15 mg/1.5 ml PDS290-15
Novo Nordisk A/S
2016 Phase 2 EUCTR2015-000531-32-SE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-DE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-BE Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-SI Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-AT Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 5 mg/1.5 ml PDS290-10
Novo Nordisk A/S
2016 Phase 2 EUCTR2015-000531-32-SE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-DE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-BE Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-SI Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-AT Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 DP 6.7 mg ml 3 ml cartridge
Novo Nordisk A/S
2014 Phase 1 EUCTR2013-000013-20-ES Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-SI Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-SE Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-BE Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-AT Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
- Phase 1 EUCTR2013-000013-20-FR Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
NNC0195-0092 PDS290 10 mg-1.5 ml
Novo Nordisk A/S
2015 Phase 3 EUCTR2013-002892-16-LV Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2013-002892-16-LT Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-002892-16-SE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-002892-16-GB Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002892-16-DE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
NNC0195-0092 PDS290 10 mg/1.5 ml
Novo Nordisk A/S
2015 Phase 3 EUCTR2014-000290-39-GB Denmark;European Union;Japan;Sweden;United Kingdom;
2015 - EUCTR2014-000290-39-DK Denmark;European Union;Japan;Sweden;United Kingdom;
2014 - EUCTR2014-000290-39-SE Denmark;European Union;Japan;Sweden;United Kingdom;
NNC126-0083
Novo Nordisk A/S
2009 Phase 2 NCT00936403 Belgium;Czech Republic;Denmark;France;Israel;Macedonia, The Former Yugoslav Republic of;Slovenia;Spain;Turkey;United Kingdom;
2008 Phase 2 NCT00715689 Denmark;
NUTROPIN
Guillem Cuatrecasas Cambra
2012 Phase 2 EUCTR2011-005377-23-ES Spain;
NUTROPINAq 10 mg/2 ml (30 UI), solución inyectable
Ipsen Pharma
2011 - EUCTR2010-020742-10-ES Finland;Spain;Sweden;United Kingdom;
Neurology examination
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Neuropsychological Testing
The University of Texas Health Science Center at San Antonio
2001 Phase 3 NCT00134420 United States;
Niacin First
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
2011 Phase 1/Phase 2 NCT01237041 United States;
None
Genexine, Inc.
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
NordiFlex
I-Mab Biopharma Co. Ltd.
2021 Phase 3 NCT04633057 China;
Nordilet®
Cinnagen
2016 Phase 3 NCT03223025 -
Norditropin
Lumos Pharma, Inc.
2021 Phase 2 EUCTR2020-000874-92-PL Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Novo Nordisk A/S
2017 Phase 3 NCT03075644 Japan;
Novo Nordisk Farma Oy
2009 Phase 4 EUCTR2008-001674-32-FI Finland;
VU University Medical Center
2013 - EUCTR2012-005066-36-NL Netherlands;
Norditropin FlexPro
Novo Nordisk A/S
2016 Phase 2 EUCTR2015-000531-32-BE Austria;Belgium;Brazil;Canada;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-000290-39-GB Denmark;European Union;Japan;Sweden;United Kingdom;
2015 Phase 3 EUCTR2013-002892-16-LV Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2013-002892-16-LT Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-000290-39-DK Denmark;European Union;Japan;Sweden;United Kingdom;
2014 Phase 3 EUCTR2013-002892-16-SE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-002892-16-GB Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002892-16-DE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 - EUCTR2014-000290-39-SE Denmark;European Union;Japan;Sweden;United Kingdom;
Norditropin FlexPro 10 mg/1.5 ml
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Novo Nordisk A/S
2020 Phase 3 EUCTR2018-000231-27-PL Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-LV Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-HU Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-ES Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-EE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-SI Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-GB Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DK Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-AT Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2016 Phase 2 EUCTR2015-000531-32-SE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2016 Phase 2 EUCTR2015-000531-32-DE Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-SI Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 2 EUCTR2015-000531-32-AT Austria;Belgium;Brazil;European Union;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
- Phase 3 EUCTR2018-000231-27-NO Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-IE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-FR Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5 mg/1.5 mL
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5 mg/1.5 ml
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Norditropin FlexPro 5mg/1.5 ml
Ascendis Pharma Endocrinology Division A/S
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Norditropin Growth Hormone
Duke University
2007 - NCT00615953 United States;
Norditropin NordiFlex®
Novo Nordisk A/S
2012 Phase 1 NCT01706783 Denmark;Sweden;
2011 - NCT01327924 France;
Norditropin NordiFlex® 10 mg/1.5 ml
Novo Nordisk A/S
2009 Phase 2 EUCTR2008-008240-25-FR Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-ES Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-SI Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-GB Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-DK Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-BE Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
Norditropin NordiFlex® 10mg/1.5 ml
Novo Nordisk A/S
2009 Phase 2 EUCTR2008-008240-25-FR Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-ES Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-SI Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-GB Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-DK Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-BE Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
Norditropin SimpleXx
Karolinska universitetssjukhuset
2006 - EUCTR2005-004478-26-SE Sweden;
Novo Nordisk A/S
2014 Phase 1 EUCTR2013-000013-20-ES Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-SI Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-SE Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-BE Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2013 - EUCTR2013-000013-20-AT Austria;Belgium;European Union;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
- Phase 1 EUCTR2013-000013-20-FR Austria;Belgium;European Union;France;Israel;Macedonia, the former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
Norditropin SimpleXx (growth hormone)
Aarhus University Hospital
2010 Phase 2 NCT01090778 Denmark;
Norditropin SimpleXx 5mg/1.5ml
University of Birmingham
2005 - EUCTR2004-004835-72-GB United Kingdom;
Norditropin Simplex
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Norditropin SimplexX (5mg/1,5 ml) (INN:somatropin)
Endocrine Department, Sahlgrenska University Hospital
2005 - EUCTR2004-004292-11-SE Sweden;
Norditropin®
Novo Nordisk A/S
2021 Phase 3 NCT04970654 China;
2019 Phase 3 NCT03811535 Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Xiamen Amoytop Biotech Co., Ltd.
2018 Phase 2/Phase 3 NCT04513171 China;
Norditropin® FlexPro®
Novo Nordisk A/S
2019 - NCT03972345 Germany;
Norditropin® FlexPro® pen
Novo Nordisk A/S
2016 Phase 2 NCT02616562 Austria;Belgium;Brazil;France;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
Norditropin® SimpleXx® 5 mg/1.5ml
Medical Department M (Endocrinology & Diabetes)
2010 Phase 2 EUCTR2010-018586-39-DK Denmark;
NuSpin
Genentech, Inc.
2010 - NCT01243892 United States;
Nutritional supplementation standardized formula
Rabin Medical Center
2017 - NCT03053687 Israel;
Nutropin AQ
Children's Hospital Los Angeles
2004 Phase 4 NCT00140413 United States;
Oregon Health and Science University
2005 Phase 4 NCT00212758 United States;
The University of Texas Health Science Center at San Antonio
2001 Phase 3 NCT00134420 United States;
Nutropin Aq
CHU Amiens
2010 - EUCTR2010-019735-35-FR France;
NutropinAq
Beaufour Ipsen Pharma
2005 - EUCTR2004-000356-17-DK Denmark;Finland;Italy;
2005 - EUCTR2004-000356-17-AT Austria;Denmark;Finland;Italy;
CHU Amiens
2010 - EUCTR2010-019735-35-FR France;
Ipsen Scandinavia
2006 - EUCTR2004-000356-17-FI Denmark;Finland;Italy;
- Phase 4 EUCTR2004-000356-17-SE Austria;Denmark;Finland;Italy;Spain;Sweden;
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
NutropinAq 10 mg/2 ml
Ipsen Pharma
2011 - EUCTR2010-020742-10-SE Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-GB Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-FI Finland;Spain;Sweden;United Kingdom;
NutropinAq 10 mg/2 ml (30 UI)
Guillem Cuatrecasas Cambra
2012 Phase 2 EUCTR2011-005377-23-ES Spain;
OMNITROPE
ASCENDIS PHARMA A/S
2010 - EUCTR2010-021523-28-IT Austria;Denmark;Germany;Italy;Sweden;
Oestrogen
University of Aarhus
2001 - NCT00572390 Denmark;
Omnitrop
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Omnitrope
Ascendis Pharma A/S
2010 Phase 2 NCT01247675 Denmark;Germany;Italy;Sweden;
Omnitrope®
Ascendis Pharma A/S
2010 - EUCTR2010-021523-28-SE Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-DK Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-DE Austria;Denmark;Germany;Italy;Sweden;
2010 - EUCTR2010-021523-28-AT Austria;Denmark;Germany;Italy;Sweden;
Once daily subcutaneous injection of Genotropin
Ascendis Pharma Endocrinology Division A/S
2016 Phase 3 NCT02781727 Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
Once weekly subcutaneous injection of TransCon hGH
Ascendis Pharma Endocrinology Division A/S
2016 Phase 3 NCT02781727 Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
Only medicinal products registered in Austria will be used in this clinical trial.
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Only medicinal products registered in Germany will be used in this clinical trial
ModigeneTech Ltd.
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Ophthalmologic evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Orthopedic evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
PEG-somatropin
GeneScience Pharmaceuticals Co., Ltd.
2017 Phase 4 NCT03290235 China;
2015 Phase 4 NCT03249480 China;
2015 Phase 4 NCT02976675 China;
2014 Phase 4 NCT02908958 China;
2014 Phase 4 NCT02380235 China;
2014 Phase 4 NCT02314676 China;
2007 Phase 3 NCT01495468 China;
PF-06836922
Pfizer Inc.
2019 Phase 3 EUCTR2018-000918-38-SK Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-GB Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-CZ Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-BG Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
PHA-794,428
PFIZER
2006 - EUCTR2005-005587-82-IT Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer
2006 - EUCTR2005-005587-82-NL Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Limited
2007 - EUCTR2005-005587-82-CZ Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2006 - EUCTR2005-005587-82-GB Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2006 - EUCTR2005-005587-82-DK Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Ltd
2007 Phase 2 EUCTR2005-005587-82-PL Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2007 - EUCTR2005-005587-82-GR Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer NV/SA
2006 - EUCTR2005-005587-82-BE Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Pharma GmbH
2006 - EUCTR2005-005587-82-DE Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
PHA-794428
Pfizer
2006 Phase 2 NCT00314938 Belgium;France;Germany;Israel;Spain;United Kingdom;
2006 Phase 2 NCT00308464 Belgium;Czech Republic;Denmark;France;Germany;Italy;Netherlands;Poland;Slovakia;Spain;Sweden;United Kingdom;
Pfizer Global Research and Development
2005 - EUCTR2005-001658-25-BE Belgium;
Pfizer Limited
2006 - EUCTR2005-005593-79-GB Germany;Spain;United Kingdom;
Pfizer N.V./S.A.
2006 - EUCTR2005-005593-79-BE Belgium;Germany;Spain;United Kingdom;
Pfizer Pharma GmbH
2006 - EUCTR2005-005593-79-DE Germany;Spain;United Kingdom;
Pfizer SA
2006 Phase 2 EUCTR2005-005593-79-ES Belgium;Germany;Spain;United Kingdom;
PN-180307
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
2010 Phase 3 EUCTR2009-017354-12-SK Czech Republic;Germany;Slovakia;Sweden;United Kingdom;
2010 Phase 3 EUCTR2009-017354-12-GB Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-SE Czech Republic;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-DE Czech Republic;Germany;Sweden;United Kingdom;
2010 - EUCTR2009-017354-12-CZ Czech Republic;Germany;Sweden;United Kingdom;
- Phase 3 EUCTR2009-017354-12-NL Czech Republic;Germany;Netherlands;Slovakia;Sweden;United Kingdom;
Pegvisomant
Oregon Health and Science University
2011 - NCT01804413 United States;
Pegylated Somatropin
GeneScience Pharmaceuticals Co., Ltd.
2006 Phase 2 NCT01342146 -
Pegylated polypeptide hormone of human recombinant origin PEG-hGH
Pfizer
2006 - EUCTR2005-005587-82-NL Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Limited
2007 - EUCTR2005-005587-82-CZ Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2006 - EUCTR2005-005593-79-GB Germany;Spain;United Kingdom;
2006 - EUCTR2005-005587-82-GB Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2006 - EUCTR2005-005587-82-DK Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Ltd
2007 Phase 2 EUCTR2005-005587-82-PL Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
2007 - EUCTR2005-005587-82-GR Czech Republic;Denmark;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer N.V./S.A.
2006 - EUCTR2005-005593-79-BE Belgium;Germany;Spain;United Kingdom;
Pfizer NV/SA
2006 - EUCTR2005-005587-82-BE Belgium;Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer Pharma GmbH
2006 - EUCTR2005-005593-79-DE Germany;Spain;United Kingdom;
2006 - EUCTR2005-005587-82-DE Czech Republic;Denmark;Germany;Greece;Italy;Netherlands;Poland;Sweden;United Kingdom;
Pfizer SA
2006 Phase 2 EUCTR2005-005593-79-ES Belgium;Germany;Spain;United Kingdom;
Pegylated recombinant human growth hormone
Ambrx, Inc., USA
2008 - EUCTR2007-001746-40-HU Hungary;
Pegylated somatropin
GeneScience Pharmaceuticals Co., Ltd.
2010 Phase 1 NCT01613573 -
Phosphate sandoz
Royal Liverpool University hospital
2006 Phase 4 EUCTR2005-004316-73-GB United Kingdom;
Pioglitazone
University of Aarhus
2004 - NCT00459940 Denmark;
Plenadren 20 mg modified-release tablets
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark;
Plenadren 5 mg modified-release tablets
Rigshospitalet, Copenhagen University Hospital
2014 Phase 4 EUCTR2014-002039-32-DK Denmark;
Polyethylene glycol
The Children's Hospital of Zhejiang University School of Medicine
2021 Phase 4 ChiCTR2100048579 China;
Psychiatric evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
R-Gene
AETERNA ZENTARIS GMBH
2021 Phase 3 EUCTR2018-001989-42-IT Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United Kingdom;United States;
R-Gene 10
Aeterna Zentaris GmbH
2021 Phase 3 EUCTR2018-001989-42-PL Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
- Phase 3 EUCTR2018-001989-42-DE Czechia;Georgia;Germany;Italy;Poland;Romania;Russian Federation;Serbia;Slovenia;Ukraine;United States;
R-hGH
Merck KGaA
2003 Phase 4 NCT01157793 -
R-hGH freeze-dried
EMD Serono
2008 Phase 1 NCT01034735 Germany;
R-hGH liquid (Saizen)
EMD Serono
2008 Phase 1 NCT01034735 Germany;
RECOMBINANT HUMAN SERUM ALBUMIN (HSA) FUSED TO HUMAN GROWTH HORMONE (HGH)
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-003796-32-PL Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-SI Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-HR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-GR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-DE Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-CZ Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-AT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-SK Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-RO Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-LT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-IT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-HU Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-ES Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-BG Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
RVG 15790 or RVG 25480
Radboud University Nijmegen Medical Centre, Department of Endocrinology
2006 Phase 4 EUCTR2006-001574-24-NL Netherlands;
Recombinanat DNA-derived human growth hormone produced in E.coli
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Recombinant DNA-derived human growth hormone
Ascendis Pharma A/S
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-GR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
Genexine, Inc.
2016 Phase 2 EUCTR2015-001939-21-PL Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Russian Federation;Serbia;Slovakia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LV Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-LT Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2016 Phase 2 EUCTR2015-001939-21-EE Belarus;Belgium;Czech Republic;Egypt;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-SK Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-HU Belarus;Czech Republic;Estonia;Greece;Hungary;Korea, Republic of;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Tunisia;Turkey;Ukraine;
2015 Phase 2 EUCTR2015-001939-21-CZ Belarus;Czech Republic;Egypt;Estonia;Greece;Hungary;Latvia;Lebanon;Lithuania;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
2015 - EUCTR2015-001939-21-GR Belarus;Belgium;Czech Republic;Egypt;Greece;Hungary;Lebanon;Morocco;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Tunisia;Turkey;Ukraine;
Hanmi Pharmaceutical Co., Ltd.
2014 - EUCTR2011-001826-61-BG Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2012 - EUCTR2011-001826-61-PL Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
2011 - EUCTR2011-001826-61-HU Bulgaria;Hungary;India;Korea, Republic of;Poland;Romania;Russian Federation;Serbia;Ukraine;
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Prolor Biotech Ltd
2010 - EUCTR2010-019374-32-CZ Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
Recombinant DNA-derived human growth hormone produced in E.coli
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
OPKO Biologics Ltd.
2013 - EUCTR2011-004553-60-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 Phase 2 EUCTR2011-004553-60-HU Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 - EUCTR2011-004553-60-SK Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 - EUCTR2011-004553-60-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
PROLOR Biotech Ltd.
2012 - EUCTR2011-004553-60-GR Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
2012 - EUCTR2011-004553-60-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Recombinant Growth Hormone, Genotropin (Pfizer)
Federico II University
1996 - NCT00462475 Italy;
Recombinant Human Gowth Hormone
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Recombinant growth hormone
University Medical Center St Radboud, department of neurology
2007 - EUCTR2006-005442-37-NL Netherlands;
Recombinant human Growth Hormone (Genotropin® )
Charite University, Berlin, Germany
2003 Phase 4 NCT00929799 Germany;
Recombinant human Growth Hormone (rhGH)
Ascendis Pharma A/S
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Prolor Biotech Ltd
2010 - EUCTR2010-019374-32-CZ Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
Recombinant human Growth Hormone(rhGH)
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
Recombinant human IGF-1
Columbia University
2008 - NCT00684957 United States;
Recombinant human growth hormone
EMD Serono
2005 Phase 3 NCT00109733 United States;
Huashan Hospital Affiliated to Fudan University
2020 Phase 0 ChiCTR2000039505 China;
Lumos Pharma, Inc.
2021 Phase 2 EUCTR2020-000874-92-PL Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Massachusetts General Hospital
2004 - NCT00182091 United States;
Sahlgrenska University Hospital
2010 - EUCTR2009-016783-37-SE Sweden;
Teva Branded Pharmaceutical Products R&D, Inc.
2013 Phase 2 NCT01811576 Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
The Children's Hospital of Zhejiang University School of Medicine
2021 Phase 4 ChiCTR2100048579 China;
The University of Texas Medical Branch, Galveston
2003 Phase 4 NCT00957671 United States;
Recombinant human growth hormone (r-hGH)
Merck KGaA
2007 Phase 4 NCT01187550 -
Recombinant human growth hormone (rhGH)
BioPartners GmbH
2015 Phase 3 EUCTR2005-000384-26-FR Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-002278-24-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-SE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-FR Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-ES Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-DE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-CZ Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-000346-36-LT Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 Phase 3 EUCTR2005-000384-26-SK Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2005-000384-26-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-SE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-DE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-CZ Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000346-36-SE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-FI Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-DE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
LG Life Science Ltd.
2005 - EUCTR2005-000384-26-ES Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-AT Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
LG Life Sciences Ltd.
2007 Phase 3 EUCTR2006-002278-24-SK Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-AT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
Recombinant human somatotropin
University of Milan
1995 - NCT00497484 Italy;
Recombinat human growth hormone
Versartis, Inc.
2015 Phase 3 EUCTR2014-004525-41-SE Belgium;Canada;Netherlands;Poland;Sweden;United States;
Regular insulin
Oregon Health and Science University
2011 - NCT01804413 United States;
RhGH Norditropin® pen (34 µg/kg)
Lumos Pharma
2020 Phase 2 NCT04614337 Australia;Israel;New Zealand;Poland;Russian Federation;Ukraine;United States;
Routine transdermal oestrogen patch
University College, London
2016 - NCT02871986 United Kingdom;
SAIZEN
Merck KGaA
2013 Phase 4 EUCTR2012-004263-47-GB Australia;Czech Republic;Germany;Sweden;United Kingdom;
2013 Phase 4 EUCTR2012-004263-47-DE Australia;Czech Republic;Germany;Sweden;United Kingdom;
2013 - EUCTR2012-004263-47-SE Australia;Czech Republic;Germany;Sweden;United Kingdom;
2013 - EUCTR2012-004263-47-CZ Australia;Czech Republic;Germany;Sweden;United Kingdom;
SOMATROPIN (recombinant DNA-derived human growth hormone)
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
SOMATROPIN FOR INJECTION
OPKO Biologics Ltd.
2017 Phase 3 EUCTR2016-003874-42-GR Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-GB Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-ES Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-DE Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-BG Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-PL Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-FR Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
Pfizer Inc.
2019 Phase 3 EUCTR2018-000918-38-SK Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-GB Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-CZ Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-BG Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Saizen
Merck KGaA, Darmstadt, Germany
2005 Phase 4 NCT00256126 Argentina;Australia;Austria;Canada;France;Germany;Italy;Norway;Russian Federation;Singapore;Spain;Sweden;United Kingdom;
Merck Serono Co., Ltd.
- - EUCTR2015-001569-20-Outside-EU/EEA China;
Merck Serono S.A.
2011 - EUCTR2010-023430-23-HU Czech Republic;Hungary;United Kingdom;
2011 - EUCTR2010-023430-23-GB Czech Republic;Hungary;United Kingdom;
2011 - EUCTR2010-023430-23-CZ Czech Republic;Hungary;United Kingdom;
ModigeneTech Ltd.
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
University Federico II
2011 - EUCTR2009-017011-16-SE Sweden;
Saizen 8mg click.easy powder for solution for injection
Merck Serono S.A. Geneva
2011 - EUCTR2011-000460-10-CZ Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
Merck Serono SA
2011 - EUCTR2011-000460-10-GB Canada;Czech Republic;Italy;Russian Federation;Spain;United Kingdom;
Saizen 8mg click.easy power for solution for injection
Merck Serono S.A. Geneva
2011 Phase 4 EUCTR2011-000460-10-ES Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
Saizen®
EMD Serono
2010 Phase 3 NCT01237340 United States;
Saizen® solution for injection (referred as Saizen®)
Merck KGaA
2013 Phase 4 NCT01806298 Australia;Czech Republic;Germany;Sweden;United Kingdom;
Saline
Massachusetts General Hospital
2004 - NCT00182091 United States;
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group)
Centro Medico Teknon
2004 Phase 2 NCT00497562 Spain;
Sodium Chloride (NaCl) IV
Rabin Medical Center
2020 - NCT04465565 Israel;
Somapacitan
Novo Nordisk A/S
2022 - NCT05230550 Japan;
2021 Phase 3 NCT04970654 China;
2019 Phase 3 NCT03811535 Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 1 NCT03905850 Germany;
2017 Phase 3 NCT03075644 Japan;
2017 Phase 1 NCT03212131 Slovakia;
2017 Phase 1 NCT03186495 Germany;
2016 Phase 2 NCT02616562 Austria;Belgium;Brazil;France;Germany;India;Israel;Japan;Slovenia;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 NCT02382939 Denmark;France;Germany;Japan;Sweden;United Kingdom;
2014 Phase 3 NCT02229851 Australia;Brazil;Germany;India;Israel;Japan;Latvia;Lithuania;Malaysia;Norway;Poland;Romania;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2013 Phase 1 NCT01973244 Austria;Belgium;France;Israel;Macedonia, The Former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2012 Phase 1 NCT01706783 Denmark;Sweden;
2012 Phase 1 NCT01514500 Germany;
Somapacitan 10 mg/1.5ml PDS290
Novo Nordisk A/S
2020 Phase 3 EUCTR2018-000231-27-PL Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-LV Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-HU Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-ES Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-EE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-SI Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-GB Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DK Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-AT Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-NO Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-IE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-FR Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 10 mg/1.5ml PDS290S
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 15 mg/1.5ml PDS290
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Novo Nordisk A/S
2020 Phase 3 EUCTR2018-000231-27-PL Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-LV Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-HU Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-ES Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-EE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-SI Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-GB Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DK Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-AT Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-NO Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-IE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-FR Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somapacitan 5 mg/1.5ml PDS290
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Novo Nordisk A/S
2020 Phase 3 EUCTR2018-000231-27-PL Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-LV Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-HU Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-ES Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2018-000231-27-EE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-SI Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-GB Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DK Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-DE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000231-27-AT Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;Hungary;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Serbia;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-NO Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Latvia;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-IE Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Serbia;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2018-000231-27-FR Algeria;Austria;Canada;Denmark;Estonia;European Union;France;Germany;India;Ireland;Israel;Japan;Korea, Republic of;Norway;Russian Federation;Slovenia;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Somatorelin
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
2004 - EUCTR2004-002125-42-IT Italy;
Somatostatin
University of Aarhus
2009 - NCT01062529 Denmark;
Somatotropin
Federico II University
2007 Phase 2 NCT01576861 Italy;
2004 Phase 2 NCT00591760 -
Somatotropine
Novo Nordisk Farma Oy
2009 Phase 4 EUCTR2008-001674-32-FI Finland;
Somatrogon
OPKO Biologics Ltd.
2017 Phase 3 EUCTR2016-003874-42-GR Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-GB Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Romania;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-003874-42-ES Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-DE Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
2017 Phase 3 EUCTR2016-003874-42-BG Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-PL Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;France;Georgia;Germany;Greece;India;Israel;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-003874-42-FR Argentina;Australia;Belarus;Brazil;Bulgaria;Canada;Chile;Colombia;France;Georgia;Germany;Greece;India;Israel;Italy;Mexico;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;Vietnam;
PRM|21097
2017 Phase 3 EUCTR2016-003874-42-IT Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
Pfizer
2019 Phase 3 NCT03831880 Bulgaria;Czechia;Slovakia;United Kingdom;United States;
Pfizer Inc.
2019 Phase 3 EUCTR2018-000918-38-SK Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-GB Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-CZ Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
2019 Phase 3 EUCTR2018-000918-38-BG Bulgaria;Czech Republic;Slovakia;United Kingdom;United States;
Somatrogon (Genetical Recombination)
OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
2017 Phase 3 JPRN-JapicCTI-183963 Japan;
Somatropin
ASCENDIS PHARMA A/S
2010 - EUCTR2010-021523-28-IT Austria;Denmark;Germany;Italy;Sweden;
Altus Pharmaceuticals
2009 Phase 2 NCT00837863 United States;
Ascendis Pharma Endocrinology Division A/S
2020 Phase 3 NCT04615273 Armenia;Australia;Canada;Georgia;Greece;Japan;Poland;Slovakia;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
BIOPARTNERS GMBH
2006 - EUCTR2005-000384-26-IT Czech Republic;Germany;Italy;Spain;Sweden;United Kingdom;
Beaufour Ipsen Pharma
2005 - EUCTR2004-000356-17-AT Austria;Denmark;Finland;Italy;
Beckert Michael
2021 Phase 3 JPRN-jRCT2051200129 Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russia;Serbia;Slovakia;Spain;Turkey;UK;USA;Ukraine;
BioPartners GmbH
2015 Phase 3 EUCTR2005-000384-26-FR Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 Phase 3 EUCTR2006-002278-24-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-SE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-FR Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-ES Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-DE Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2006-002278-24-CZ Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
2006 - EUCTR2005-000346-36-LT Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 Phase 3 EUCTR2005-000384-26-SK Austria;Czech Republic;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 Phase 3 EUCTR2005-000384-26-GB Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-SE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-DE Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-CZ Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000346-36-SE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-FI Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
2005 - EUCTR2005-000346-36-DE Austria;Czech Republic;Estonia;Finland;Germany;Hungary;Italy;Latvia;Lithuania;Sweden;
Daewoong Pharmaceutical Co. LTD.
2003 Phase 3 NCT02693522 Korea, Republic of;
Eli Lilly and Company
2004 Phase 3 NCT00191165 Italy;
2003 Phase 3 NCT00191360 Japan;
1999 Phase 4 NCT00490191 France;Germany;Italy;Puerto Rico;United Kingdom;United States;
1997 Phase 3 NCT00570011 United States;
Ferring Pharmaceuticals
2014 - NCT02018172 France;
2013 - NCT01731028 -
2007 - NCT01306357 France;
Ferring Pharmaceuticals A/S
2009 - EUCTR2008-004849-28-HU Hungary;
Genentech, Inc.
2015 Phase 4 NCT02311894 United States;
2010 - NCT01243892 United States;
Genexine, Inc
2015 Phase 2 EUCTR2014-002698-13-SK France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-SE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-PL France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-HU France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-GR France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
2015 Phase 2 EUCTR2014-002698-13-DE France;Germany;Greece;Hungary;Korea, Republic of;Poland;Serbia;Slovakia;Sweden;
HanAll BioPharma Co., Ltd.
2011 Phase 1 NCT01440686 Korea, Republic of;
Ioroi Minoru
2021 Phase 2 JPRN-jRCT2031210366 Japan;
2021 Phase 2 JPRN-jRCT2031200372 Japan;
Ipsen Pharma
2011 - EUCTR2010-020742-10-SE Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-GB Finland;Spain;Sweden;United Kingdom;
2011 - EUCTR2010-020742-10-FI Finland;Spain;Sweden;United Kingdom;
Karolinska universitetssjukhuset
2006 - EUCTR2005-004478-26-SE Sweden;
L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
2013 Phase 1 NCT01494779 Brazil;
LG Life Science Ltd.
2005 - EUCTR2005-000384-26-ES Czech Republic;Germany;Spain;Sweden;United Kingdom;
2005 - EUCTR2005-000384-26-AT Austria;Czech Republic;Germany;Spain;Sweden;United Kingdom;
LG Life Sciences
2016 Phase 4 NCT03015909 Korea, Republic of;
LG Life Sciences Ltd.
2007 Phase 3 EUCTR2006-002278-24-SK Austria;Czech Republic;France;Germany;Slovakia;Spain;Sweden;United Kingdom;
2007 - EUCTR2006-002278-24-AT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
Massachusetts General Hospital
2002 - NCT00136032 United States;
Merck Serono S.A. Geneva
2011 Phase 4 EUCTR2011-000460-10-ES Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
2011 - EUCTR2011-000460-10-CZ Argentina;Canada;Czech Republic;France;Italy;Spain;United Kingdom;
Merck Serono SA
2011 - EUCTR2011-000460-10-GB Canada;Czech Republic;Italy;Russian Federation;Spain;United Kingdom;
ModigeneTech Ltd.
2011 - EUCTR2010-019374-32-AT Austria;Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SK Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-SI Czech Republic;Germany;Hungary;Slovakia;Slovenia;
2010 - EUCTR2010-019374-32-HU Czech Republic;Germany;Hungary;Slovakia;Slovenia;
- - EUCTR2010-019374-32-DE Czech Republic;Germany;Hungary;Slovakia;Slovenia;
NOVO NORDISK. S.P.A.
2019 Phase 3 EUCTR2018-000231-27-IT Algeria;Austria;Canada;Denmark;Estonia;France;Germany;Hungary;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Norway;Poland;Russian Federation;Slovenia;Spain;Switzerland;Thailand;Ukraine;United Kingdom;United States;
Novo Nordisk A/S
2015 Phase 3 NCT02382939 Denmark;France;Germany;Japan;Sweden;United Kingdom;
2015 Phase 3 EUCTR2014-000290-39-GB Denmark;European Union;Japan;Sweden;United Kingdom;
2015 Phase 3 EUCTR2013-002892-16-LV Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2015 Phase 3 EUCTR2013-002892-16-LT Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-000290-39-DK Denmark;European Union;Japan;Sweden;United Kingdom;
2014 Phase 3 NCT02229851 Australia;Brazil;Germany;India;Israel;Japan;Latvia;Lithuania;Malaysia;Norway;Poland;Romania;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002892-16-SE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 Phase 3 EUCTR2013-002892-16-GB Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United Kingdom;United States;
2014 Phase 3 EUCTR2013-002892-16-DE Australia;Brazil;European Union;Germany;India;Japan;Latvia;Lithuania;Malaysia;Russian Federation;South Africa;Sweden;Turkey;Ukraine;United States;
2014 - EUCTR2014-000290-39-SE Denmark;European Union;Japan;Sweden;United Kingdom;
2013 Phase 1 NCT01973244 Austria;Belgium;France;Israel;Macedonia, The Former Yugoslav Republic of;Norway;Slovenia;Spain;Sweden;Switzerland;
2009 Phase 2 NCT00936403 Belgium;Czech Republic;Denmark;France;Israel;Macedonia, The Former Yugoslav Republic of;Slovenia;Spain;Turkey;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-FR Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 Phase 2 EUCTR2008-008240-25-ES Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2009 - NCT01109017 Japan;
2009 - NCT00934063 Germany;
2009 - EUCTR2008-008240-25-SI Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-GB Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-DK Denmark;France;Slovenia;Spain;United Kingdom;
2009 - EUCTR2008-008240-25-BE Belgium;Denmark;France;Slovenia;Spain;United Kingdom;
2006 - NCT00960128 Argentina;Belgium;Brazil;Czech Republic;Czechia;Denmark;Finland;Former Serbia and Montenegro;France;Germany;Hungary;Ireland;Israel;Italy;Lithuania;Luxembourg;Netherlands;Norway;Russian Federation;Saudi Arabia;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;
2005 - NCT01604161 Japan;
2004 Phase 3 NCT00184730 Japan;
2003 Phase 4 NCT00567385 Turkey;
2003 Phase 3 NCT00519558 Japan;
2003 Phase 3 NCT00184743 Japan;
2003 - NCT01580605 France;
2003 - NCT01543880 Germany;
2002 Phase 3 NCT00184678 Australia;Austria;Belgium;France;Germany;Hungary;Norway;Poland;Spain;Sweden;Switzerland;United Kingdom;
2002 - NCT01009905 United States;
2001 Phase 4 NCT01698944 Greece;
2001 Phase 3 NCT01502124 United States;
2001 - NCT01543867 Germany;
2000 Phase 3 NCT01563926 Israel;
2000 Phase 3 NCT00262249 United States;
2000 Phase 1 NCT00931476 United States;
1998 Phase 4 NCT01562834 France;
OPKO Biologics Ltd.
2013 - EUCTR2011-004553-60-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 Phase 2 EUCTR2011-004553-60-HU Belarus;Bulgaria;Czech Republic;Greece;Hungary;Poland;Russian Federation;Slovakia;Ukraine;United States;
2012 - EUCTR2011-004553-60-SK Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
2012 - EUCTR2011-004553-60-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Ukraine;United States;
OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)
2017 Phase 3 JPRN-JapicCTI-183963 Japan;
OPKO Health, Inc.
2016 Phase 3 NCT02968004 Argentina;Australia;Belarus;Bulgaria;Canada;Colombia;Georgia;Germany;Greece;India;Israel;Italy;Korea, Republic of;Mexico;New Zealand;Poland;Russian Federation;Spain;Taiwan;Turkey;Ukraine;United Kingdom;United States;
2012 Phase 2 NCT01592500 Greece;Hungary;Slovakia;
PRM|21097
2017 Phase 3 EUCTR2016-003874-42-IT Bulgaria;France;Germany;Greece;Italy;Poland;Spain;United Kingdom;
PROLOR Biotech Ltd.
2012 - EUCTR2011-004553-60-GR Belarus;Czech Republic;Greece;Hungary;Israel;Macedonia, the former Yugoslav Republic of;Russian Federation;Ukraine;
2012 - EUCTR2011-004553-60-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Slovakia;Spain;Ukraine;United States;
Pfizer
2008 Phase 3 NCT00630487 Germany;
2007 - NCT00601419 -
2005 Phase 3 NCT00163189 France;
1997 Phase 3 NCT00174278 France;
Pfizer Pharma GmbH
2008 - EUCTR2007-000790-36-DE Germany;
Prolor Biotech Ltd
2010 - EUCTR2010-019374-32-CZ Czech Republic;Germany;Hungary;Israel;Serbia;Slovakia;Slovenia;
Teva Pharmaceutical Industries, Ltd.
2014 Phase 2 NCT02092077 Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
The Children's Hospital, Zhejiang University School of Medicine
2018 - ChiCTR1800017144 China‘;
University of Birmingham
2005 - EUCTR2004-004835-72-GB United Kingdom;
VA Office of Research and Development
2022 Phase 3 NCT04867317 United States;
Somatropin (INN) recombinant DNA orgin, Escherichia coli
Beaufour Ipsen Pharma
2005 - EUCTR2004-000356-17-DK Denmark;Finland;Italy;
Somatropin (rDNA origin)
Eli Lilly and Company
2002 - NCT01088399 -
Somatropin (recombinant DNA origin produced in E. coli)
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-IT Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
Somatropin AQ
GeneScience Pharmaceuticals Co., Ltd.
2010 Phase 1 NCT01613573 -
Somatropin Injection
GeneScience Pharmaceuticals Co., Ltd.
2017 Phase 2 NCT03104010 China;
Somatropin injection
Nemours Children's Clinic
2019 - NCT04020913 United States;
Somatropina
Pfizer, S.A
2007 Phase 4 EUCTR2007-003586-41-ES France;Italy;Netherlands;Spain;Sweden;United Kingdom;
Somatropine
Sanofi
2003 Phase 3 NCT00476385 France;
Somavaratan
Versartis Inc.
2017 Phase 3 NCT03145831 Japan;United States;
2016 Phase 2 NCT02719990 Australia;United States;
2015 Phase 3 NCT02339090 Belgium;Canada;Netherlands;Poland;Sweden;United States;
2015 Phase 2 NCT02526420 Australia;Germany;United Kingdom;United States;
2015 Phase 2 EUCTR2015-002072-24-DE Australia;Germany;United Kingdom;United States;
2014 Phase 2/Phase 3 NCT02068521 United States;
Versartis, Inc.
2017 Phase 3 EUCTR2016-002780-34-PL Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2016-002780-34-SE Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2016-002780-34-BE Belgium;Canada;Poland;Sweden;United States;
Somavaratan (VRS-317)
Versartis Inc.
2015 Phase 2/Phase 3 NCT02413138 Japan;
Versartis, Inc.
2015 Phase 3 EUCTR2014-004525-41-SE Belgium;Canada;Netherlands;Poland;Sweden;United States;
Speech pathology evaluation
The University of Texas Health Science Center at San Antonio
1993 - NCT00227253 United States;
Sterile Water for Injection
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Strontium ranelate
Royal Liverpool University hospital
2006 Phase 4 EUCTR2005-004316-73-GB United Kingdom;
Sustained release growth hormone
BIOPARTNERS GMBH
2007 - EUCTR2006-002278-24-IT Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom;
Sustained-release recombinant human GH (SR-rhGH)
LG Life Sciences
2009 Phase 4 NCT01605331 -
Synacthen
Cardiff University
2008 Phase 4 EUCTR2007-000056-14-GB United Kingdom;
University of Wuerzburg
2005 - NCT00552487 Germany;
Synacthen (Tetracosactrin)
Cardiff University
2008 Phase 4 NCT00851942 United Kingdom;
Syntropin
Phage Pharmaceuticals, Inc.
2004 Phase 1 NCT00489294 United States;
TJ101
I-Mab Biopharma Co. Ltd.
2021 Phase 3 NCT04633057 China;
TRANSCON PEG40 HGH
Ascendis Pharma Endocrinology Division A/S
2022 Phase 3 EUCTR2020-000929-42-BG Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-SK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-GR Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-ES Armenia;Australia;Belarus;Bulgaria;Canada;China;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Serbia;Slovakia;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DK Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000929-42-DE Armenia;Australia;Belarus;Bulgaria;Canada;Denmark;France;Georgia;Germany;Greece;Israel;Italy;Japan;Netherlands;New Zealand;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;United Kingdom;United States;
2018 Phase 3 EUCTR2017-003410-20-PL Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-IT Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-GR Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-BG Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
TRANSCON PEG40 HGH, Transiently PEGylated hGH prodrug
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TV-1106
Teva Branded Pharmaceutical Products R&D, Inc.
2015 Phase 3 NCT02410356 Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 NCT02410343 Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;Czechia;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2013 Phase 2 NCT01811576 Czech Republic;Czechia;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Teva Pharmaceutical Industries Ltd.
2016 - EUCTR2014-003796-32-PL Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Ukraine;United States;
2016 - EUCTR2014-002736-13-PL Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-SI Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-HR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-GR Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-DE Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-CZ Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-003796-32-AT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SI Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-SE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HU Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-HR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-GR Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-DE Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-CZ Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 Phase 3 EUCTR2014-002736-13-AT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-SK Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-RO Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-LT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-IT Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-HU Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-ES Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-003796-32-BG Argentina;Austria;Belarus;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-SK Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-LT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-IT Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2015 - EUCTR2014-002736-13-ES Argentina;Austria;Brazil;Bulgaria;Canada;Chile;Croatia;Czech Republic;France;Georgia;Germany;Greece;Hungary;Israel;Italy;Lithuania;Mexico;Peru;Poland;Romania;Russian Federation;Serbia;Slovakia;Slovenia;Spain;Sweden;Turkey;Ukraine;United States;
2013 Phase 2 EUCTR2012-004975-37-DE Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SK Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-SI Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-SE Czech Republic;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-HU Czech Republic;Denmark;France;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
2013 - EUCTR2012-004975-37-GR Czech Republic;Denmark;France;Germany;Greece;Hungary;Slovakia;Slovenia;Sweden;
2013 - EUCTR2012-004975-37-CZ Czech Republic;Germany;Greece;Hungary;Israel;Serbia;Slovakia;Slovenia;Sweden;United States;
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 NCT02092077 Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
TV1106
Teva Pharmaceutical Industries, Ltd.
2015 Phase 2 EUCTR2013-004468-69-PL Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 Phase 2 EUCTR2013-004468-69-BG Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2015 - EUCTR2013-004468-69-ES Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-HU Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovenia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-GR Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
2014 Phase 2 EUCTR2013-004468-69-CZ Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Slovakia;Spain;Turkey;Ukraine;
- Phase 2 EUCTR2013-004468-69-RO Belarus;Bulgaria;Czech Republic;Georgia;Greece;Hungary;Israel;Poland;Romania;Russian Federation;Serbia;Spain;Turkey;Ukraine;
Tesamorelin
Columbia University
2018 Phase 4 NCT03226821 United States;
Testogel
Dr. Chris Thompson
2006 - EUCTR2005-005613-38-IE Ireland;
Testosterone plus somatropin
University of Pennsylvania
2004 Phase 2 NCT00080483 United States;
TheraDerm
Massachusetts General Hospital
2001 - NCT00027430 United States;
Thyroxin, Triiodothyronine
University Hospital Freiburg
2004 Phase 4 NCT00360074 Germany;
Tiratricol
Rare Thyroid Therapeutics International
2020 Phase 2 EUCTR2019-003370-35-IT Czech Republic;Czechia;France;Germany;Italy;Netherlands;United Kingdom;United States;
TransCon hGH
Ascendis Pharma A/S
2017 Phase 3 NCT03344458 Armenia;Australia;Belarus;Bulgaria;Georgia;Greece;New Zealand;Poland;Russian Federation;Ukraine;United States;
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 NCT03305016 Australia;Canada;New Zealand;United States;
Visen Pharmaceuticals (Shanghai) Co., Ltd.
2019 Phase 3 NCT04326374 China;
TransCon hGH (ACP-011)
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2017-003410-20-PL Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-IT Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Germany;Greece;Italy;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-GR Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2018 Phase 3 EUCTR2017-003410-20-BG Armenia;Australia;Belarus;Bulgaria;Canada;Georgia;Greece;Italy;New Zealand;Poland;Romania;Russian Federation;Turkey;Ukraine;United States;
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH (ACP-011) -
Ascendis Pharma Endocrinology Division A/S
2018 Phase 3 EUCTR2016-001145-11-DE Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-PL Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
- Phase 3 EUCTR2016-001145-11-BG Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH (ACP-011) - 12,
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
TransCon hGH CT-301 (ACP-011) - 12,
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Transdermal Testosterone gel
Charles Drew University of Medicine and Science
2003 Phase 4 NCT00144391 United States;
Transiently PEGylated hGH prodrug
Ascendis Pharma A/S
2013 Phase 2 EUCTR2012-002787-27-SI Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-GR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-DE Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 Phase 2 EUCTR2012-002787-27-CZ Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-HU Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
2013 - EUCTR2012-002787-27-BG Armenia;Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
- Phase 2 EUCTR2012-002787-27-FR Belarus;Bulgaria;Czech Republic;Egypt;France;Germany;Greece;Hungary;Poland;Romania;Russian Federation;Slovenia;Turkey;Ukraine;
Ascendis Pharma Endocrinology Division A/S
2017 Phase 3 EUCTR2016-001145-11-IT Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2017 Phase 3 EUCTR2016-001145-11-GR Armenia;Australia;Azerbaijan;Belarus;Brazil;Bulgaria;Canada;Chile;Egypt;France;Georgia;Germany;Greece;Italy;Jordan;Kazakhstan;Kyrgyzstan;Lebanon;Lithuania;New Zealand;Poland;Romania;Russian Federation;South Africa;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Trisequens
Dr. Chris Thompson
2006 - EUCTR2005-005613-38-IE Ireland;
VRS-317
Versartis Inc.
2015 Phase 2 EUCTR2015-002072-24-DE Australia;Germany;United Kingdom;United States;
2011 Phase 1 NCT01359488 United States;
Versartis, Inc.
2017 Phase 3 EUCTR2016-002780-34-PL Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2016-002780-34-SE Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2016-002780-34-BE Belgium;Canada;Poland;Sweden;United States;
2016 Phase 3 EUCTR2014-004525-41-PL Belgium;Canada;Netherlands;Poland;Sweden;United States;
2015 Phase 3 EUCTR2014-004525-41-BE Belgium;Canada;Netherlands;Poland;Sweden;United States;
2015 - EUCTR2014-004525-41-NL Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Spain;Sweden;United Kingdom;United States;
Y-shape pegylated somatropin
Xiamen Amoytop Biotech Co., Ltd.
2018 Phase 2/Phase 3 NCT04513171 China;
ZD1033
Nemours Children's Clinic
- - EUCTR2012-001183-30-Outside-EU/EEA United States;
Zomacton
Ferring Pharmaceuticals
2018 - NCT03274973 Germany;
2010 Phase 3 NCT00884000 Hungary;India;Israel;Poland;Romania;Russian Federation;Ukraine;
VU University Medical Center
2013 - EUCTR2012-005066-36-NL Netherlands;
Zomacton 10 mg/ml
Ferring Pharmaceuticals A/S
2009 - EUCTR2008-004849-28-HU Hungary;